1
|
Wang Y, Lu BH, Gao Y, Liu YX, Hu MM, Che NY, Lin HF, Li HX, Zhang HM, Zhang TM. [Aprospective study of detection and clinical significance of bone marrow tumor cells in small cell lung cancer]. Zhonghua Zhong Liu Za Zhi 2024; 46:419-427. [PMID: 38742355 DOI: 10.3760/cma.j.cn112152-20231014-00193] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 05/16/2024]
Abstract
Objective: To investigate the detection of bone marrow tumor cells in small cell lung cancer (SCLC) patients and their relationship with clinical features, treatment response and prognosis. Methods: A total of 113patients with newly diagnosed SCLC from January 2018 to October 2022 at Beijing Chest Hospital were prospectively enrolled. Before treatment, bone marrow was aspirated and separately submitted for tumor cells detection by liquid-based cytology and disseminated tumor cells (DTCs) detection by the substrction enrichment and immunostaining fluorescence in situ hybridization (SE-iFISH) platform. The correlation between the detection results of the two methods with patients' clinical features and treatment response was evaluated by Chi-square. Kaplan-Meier method was applied to create survival curves and the Cox regression model was used for multivariate analysis. Results: The positive rate of bone marrow liquid-based cytology in SCLC was 15.93% (18/113). The liver and bone metastases rates were significantly higher (55.56% vs 11.58% for liver metastasis, P<0.001; 77.78% vs 16.84% for bone metastasis, P<0.001) and thrombocytopenia was more common (16.67% vs 2.11%, P=0.033) in patients with tumor cells detected in liquid-based cytology than those without detected tumor cells. As for SE-iFISH, DTCs were detected in 92.92% of patients (105/113), the liver and bone metastasis rates were significantly higher (37.93% vs 11.90% for liver metastasis, P=0.002; 44.83% vs 20.23 % for bone metastasis, P=0.010), and the incidence of thrombocytopenia was significantly increased (13.79% vs 1.19%, P=0.020) in patients with DTCs≥111 per 3 ml than those with DTCs<111 per 3 ml. The positive rates of bone marrow liquid-based cytology in the disease control group and the disease progression group were 12.00% (12/100) and 46.15% (6/13), respectively, and the difference was statistically significant (P=0.002). However, the result of SE-iFISH revealed the DTCs quantities of the above two groups were 29 (8,110) and 64 (15,257) per 3 ml, and there was no statistical difference between the two groups (P=0.329). Univariate analysis depicted that the median progression-free survival (PFS) and median overall survival (OS) of liquid-based cytology positive patients were significantly shorter than those of tumor cell negative patients (6.33 months vs 9.27 months for PFS, P=0.019; 8.03 months vs 19.50 months for OS, P=0.019, P=0.033). The median PFS and median OS in patients with DTCs≥111 per 3 ml decreased significantly than those with DTCs<111 per 3 ml (6.83 months vs 9.50 months for PFS, P=0.004; 11.2 months vs 20.60 months for OS, P=0.019). Multivariate analysis showed that disease stage (HR=2.806, 95%CI:1.499-5.251, P=0.001) and DTCs quantity detected by SE-iFISH (HR=1.841, 95%CI:1.095-3.095, P=0.021) were independent factors of PFS, while disease stage was the independent factor of OS (HR=2.538, 95%CI:1.169-5.512, P=0.019). Conclusions: Both bone marrow liquid-based cytology and SE-iFISH are clinically feasible. The positive detection of liquid-based cytology or DTCs≥111 per 3 ml was correlated with distant metastasis, and DTCs≥111 per 3 ml was an independent prognostic factor of decreased PFS in SCLC.
Collapse
Affiliation(s)
- Y Wang
- Department of Oncology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China
| | - B H Lu
- Department of Oncology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China
| | - Y Gao
- Department of Oncology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China
| | - Y X Liu
- Department of Oncology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China
| | - M M Hu
- Department of Oncology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China
| | - N Y Che
- Department of Pathology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China
| | - H F Lin
- Department of Pathology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China
| | - H X Li
- Department of Oncology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China Laboratory for Clinical Medicine, Capital Medical University, Beijing 101149, China
| | - H M Zhang
- Department of Oncology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China
| | - T M Zhang
- Department of Oncology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China Laboratory for Clinical Medicine, Capital Medical University, Beijing 101149, China
| |
Collapse
|
2
|
Xing K, Zhang H, Wang S, Li J, Mu Z, Zhang L, Zuo S, Wang Y, Li S, Wu B, Jing Y, Wen J, Liu D, Huang M, Zhao L. Design, synthesis and biological evaluation of 4-(indolin-1-yl)-6-substituted-pyrido[3,2-d]pyrimidine derivatives as Mnk1/2 inhibitors. Eur J Med Chem 2024; 272:116499. [PMID: 38759457 DOI: 10.1016/j.ejmech.2024.116499] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2024] [Revised: 05/10/2024] [Accepted: 05/12/2024] [Indexed: 05/19/2024]
Abstract
The Mnk-eIF4E axis plays a crucial role in tumor development, and inhibiting Mnk kinases is a promising approach for cancer therapy. Starting with fragment WS23, a series of 4-(indolin-1-yl)-6-substituted-pyrido[3,2-d]pyrimidine derivatives were designed and synthesized. Among these derivatives, compound 15b showed the highest potency with IC50 values of 0.8 and 1.5 nM against Mnk1 and Mnk2, respectively. Additionally, it demonstrated good selectivity among 30 selected kinases. 15b significantly suppressed MOLM-13 and K562 cell lines growth and caused cell cycle arrest. Furthermore, the Western blot assay revealed that 15b effectively downregulated the downstream proteins p-eIF4E, Mcl-1, and c-myc. Additionally, 15b exhibited remarkable stability in rat plasma and rat and human microsomes. In vivo anti-tumor activity study suggested that treatment with 15b suppressed tumor growth in LL/2 syngeneic models. These findings highlight the potential of 15b as a novel and potent Mnks inhibitor, which deserves further investigation.
Collapse
Affiliation(s)
- Kun Xing
- Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China
| | - Huimin Zhang
- Liaoning Key Laboratory of Targeting Drugs for Hematological Malignancies, Shenyang Pharmaceutical University, Shenyang, 110016, China
| | - Shuxiang Wang
- Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China
| | - Jinghuan Li
- Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China
| | - Zhiying Mu
- Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China
| | - Lanxin Zhang
- Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China
| | - Shuwei Zuo
- Liaoning Key Laboratory of Targeting Drugs for Hematological Malignancies, Shenyang Pharmaceutical University, Shenyang, 110016, China
| | - Yuetong Wang
- Liaoning Key Laboratory of Targeting Drugs for Hematological Malignancies, Shenyang Pharmaceutical University, Shenyang, 110016, China
| | - Shujun Li
- Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China
| | - Boyang Wu
- Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China
| | - Yongkui Jing
- Liaoning Key Laboratory of Targeting Drugs for Hematological Malignancies, Shenyang Pharmaceutical University, Shenyang, 110016, China
| | - Jiachen Wen
- Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China
| | - Dan Liu
- Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China
| | - Min Huang
- Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China.
| | - Linxiang Zhao
- Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China.
| |
Collapse
|
3
|
Li Z, Ouyang Z, Zhang H, Mi C, Dong N, Niu Y, Qiang C, Yang J, Wang W, Li Y, Zhao J. Novel target and PCR assay for identification of hypervirulent ST1 (BI/NAP1/027) Clostridioides difficile and detection of toxigenic C. Difficile. Clin Chim Acta 2024; 559:119728. [PMID: 38750779 DOI: 10.1016/j.cca.2024.119728] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2024] [Accepted: 05/12/2024] [Indexed: 05/19/2024]
Abstract
BACKGROUND AND AIMS The incidence of Clostridioides difficile infection and the prevalence of hypervirulent ST1 (BI/NAP1/027)strain are increasing, especially in developing countries. We aimed to develop a new PCR assay for the identification of hypervirulent ST1 strains and toxigenic C. difficile in stool samples. MATERIALS AND METHODS We established a quadruplex TaqMan real-time PCR (pilW_4-plex PCR) assay targeting the pilW, a ST1-specific type Ⅳ minor pilin gene, and three C. difficile genes including cdtB, tcdB, and hsp. The sensitivity and specificity of the assay was tested using 403C. difficile isolates and 180 unformed stool sample. The results were compared with anaerobic culture-based conventional PCR method and MLST. RESULTS The pilW_4-plex PCR identified toxigenic C. difficile in 333 (82.6%, 333/403) isolates with 100% sensitivity and specificity, and in 78 (43.3%, 78/180) stool samples with the sensitivity and specificity of 94.7% and 93.3%, respectively. Hypervirulent ST1 were detected in 21 strains and nine stool samples by the pilW_4-plex PCR. The pilW_4-plex PCR assay has no cross-reaction with non-toxigenic C. difficile or other bacteria. CONCLUSION The pilW_4-plex PCR assay is an accurate and rapid method with high sensitivity and specificity for identification of ST1 and detection of toxigenic C. difficile in stool.
Collapse
Affiliation(s)
- Zhirong Li
- Hebei Provincial Center for Clinical Laboratories, The Second Hospital of Hebei Medical University, Shijiazhuang, China
| | - Zirou Ouyang
- Hebei Provincial Center for Clinical Laboratories, The Second Hospital of Hebei Medical University, Shijiazhuang, China
| | - Huimin Zhang
- Hebei Provincial Center for Clinical Laboratories, The Second Hospital of Hebei Medical University, Shijiazhuang, China
| | - Chaoyi Mi
- Research Center, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China; Clinical Oncology Research Center, Shijiazhuang, China Key Laboratory of Tumor Gene Diagnosis, Prevention and Therapy; Clinical Oncology Research Center, Shijiazhuang, ChinaClinical Oncology Research Center, Shijiazhuang, China
| | - Ning Dong
- Hebei Provincial Center for Clinical Laboratories, The Second Hospital of Hebei Medical University, Shijiazhuang, China
| | - Yanan Niu
- Hebei Provincial Center for Clinical Laboratories, The Second Hospital of Hebei Medical University, Shijiazhuang, China
| | - Cuixin Qiang
- Hebei Provincial Center for Clinical Laboratories, The Second Hospital of Hebei Medical University, Shijiazhuang, China
| | - Jing Yang
- Hebei Provincial Center for Clinical Laboratories, The Second Hospital of Hebei Medical University, Shijiazhuang, China
| | - Weigang Wang
- Hebei Provincial Center for Clinical Laboratories, The Second Hospital of Hebei Medical University, Shijiazhuang, China
| | - Yanhong Li
- Comprehensive Surgical Department, Hebei Provincial Hospital of Traditional Chinese Medicine, Shijiazhuang, China
| | - Jianhong Zhao
- Hebei Provincial Center for Clinical Laboratories, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
| |
Collapse
|
4
|
Hou Y, Zhang H, Zhu Y, He X, Li W, Su L, Liu M, Chen X, Shen F, Chen X, Jiang W, Zou C, Xu Z. Erratum to "Targeting upregulation of the immunosuppressive activity of MDSCs with indirubin as a novel strategy to alleviate psoriasis" [Int. Immunopharmacol. 123 (2023) 110710]. Int Immunopharmacol 2024; 132:111756. [PMID: 38553334 DOI: 10.1016/j.intimp.2024.111756] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/01/2024]
Affiliation(s)
- Yifei Hou
- Shanghai Key Laboratory of Health Identification and Assessment, School of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
| | - Huimin Zhang
- Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200021, China
| | - Yangzhuangzhuang Zhu
- Shanghai Key Laboratory of Health Identification and Assessment, School of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
| | - Xufeng He
- Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200021, China
| | - Wen Li
- Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200021, China
| | - Lin Su
- Shanghai Key Laboratory of Health Identification and Assessment, School of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
| | - Mingxi Liu
- Shanghai Key Laboratory of Health Identification and Assessment, School of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
| | - Xi Chen
- Department of Traditional Chinese Medicine Dermatology, Shanghai Skin Disease Hospital, Shanghai 200443, China
| | - Fang Shen
- Department of Traditional Chinese Medicine Dermatology, Shanghai Skin Disease Hospital, Shanghai 200443, China
| | - Xiao Chen
- Shanghai Key Laboratory of Health Identification and Assessment, School of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
| | - Wencheng Jiang
- Department of Traditional Chinese Medicine Dermatology, Shanghai Skin Disease Hospital, Shanghai 200443, China.
| | - Chunpu Zou
- Shanghai Key Laboratory of Health Identification and Assessment, School of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
| | - Zihang Xu
- Shanghai Key Laboratory of Health Identification and Assessment, School of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
| |
Collapse
|
5
|
Shan D, Chen W, Liu G, Zhang H, Chai S, Zhang Y. Severe fever with thrombocytopenia syndrome with central nervous system symptom onset: a case report and literature review. BMC Neurol 2024; 24:158. [PMID: 38730325 PMCID: PMC11084135 DOI: 10.1186/s12883-024-03664-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2023] [Accepted: 05/02/2024] [Indexed: 05/12/2024] Open
Abstract
BACKGROUND Severe fever with thrombocytopenia syndrome (SFTS) is a natural focal disease transmitted mainly by tick bites, and the causative agent is SFTS virus (SFTSV). SFTS can rapidly progress to severe disease, with multiple-organ failure (MOF) manifestations such as shock, respiratory failure, disseminated intravascular coagulation (DIC) and death, but cases of SFTS patients with central nervous system (CNS) symptoms onset and marked persistent involuntary shaking of the perioral area and limbs have rarely been reported. CASE PRESENTATION A 69-year-old woman with fever and persistent involuntary shaking of the perioral area and limbs was diagnosed with SFTS with CNS symptom onset after metagenomic next-generation sequencing (mNGS) of cerebrospinal fluid (CSF) and peripheral blood identified SFTSV. The patient developed a cytokine storm and MOF during the course of the disease, and after aggressive antiviral, glucocorticoid, and gamma globulin treatments, her clinical symptoms improved, her laboratory indices returned to normal, and she had a good prognosis. CONCLUSION This case gives us great insight that when patients with CNS symptoms similar to those of viral encephalitis combined with thrombocytopenia and leukopenia are encountered in the clinic, it is necessary to consider the possibility of SFTS involving the CNS. Testing for SFTSV nucleic acid in CSF and blood (mNGS or polymerase chain reaction (PCR)) should be carried out, especially in critically ill patients, and treatment should be given accordingly.
Collapse
Affiliation(s)
- Dawei Shan
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China
| | - Weibi Chen
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China
| | - Gang Liu
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China
| | - Huimin Zhang
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China
| | - Shuting Chai
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China
| | - Yan Zhang
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
| |
Collapse
|
6
|
Zhang H, Qiao Q, Zhao Y, Zhang L, Shi J, Wang N, Li Z, Shan S. Expression and Purification of Recombinant Bowman-Birk Trypsin Inhibitor from Foxtail Millet Bran and Its Anticolorectal Cancer Effect In Vitro and In Vivo. J Agric Food Chem 2024; 72:10439-10450. [PMID: 38676695 DOI: 10.1021/acs.jafc.3c08711] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/29/2024]
Abstract
Trypsin inhibitors derived from plants have various pharmacological activities and promising clinical applications. In our previous study, a Bowman-Birk-type major trypsin inhibitor from foxtail millet bran (FMB-BBTI) was extracted with antiatherosclerotic activity. Currently, we found that FMB-BBTI possesses a prominent anticolorectal cancer (anti-CRC) activity. Further, a recombinant FMB-BBTI (rFMB-BBTI) was successfully expressed in a soluble manner in host strain Escherichia coli. BL21 (DE3) was induced by isopropyl-β-d-thiogalactoside (0.1 mM) at 37 °C for 3.5 h by the pET28a vector system. Fortunately, a purity greater than 93% of rFMB-BBTI with anti-CRC activity was purified by nickel-nitrilotriacetic acid affinity chromatography. Subsequently, we found that rFMB-BBTI displays a strikingly anti-CRC effect, characterized by the inhibition of cell proliferation and clone formation ability, cell cycle arrest at the G2/M phase, and induction of cell apoptosis. It is interesting that the rFMB-BBTI treatment had no obvious effect on normal colorectal cells in the same concentration range. Importantly, the anti-CRC activity of rFMB-BBTI was further confirmed in the xenografted nude mice model. Taken together, our study highlights the anti-CRC activity of rFMB-BBTI in vitro and in vivo, uncovering the clinical potential of rFMB-BBTI as a targeted agent for CRC in the future.
Collapse
Affiliation(s)
- Huimin Zhang
- Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education, Shanxi University, Taiyuan 030006, China
| | - Qinqin Qiao
- Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education, Shanxi University, Taiyuan 030006, China
| | - Yaru Zhao
- School of Life Science, Shanxi University, Taiyuan 030006, China
| | - Lizhen Zhang
- School of Life Science, Shanxi University, Taiyuan 030006, China
| | - Jiangying Shi
- Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education, Shanxi University, Taiyuan 030006, China
| | - Nifei Wang
- Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education, Shanxi University, Taiyuan 030006, China
| | - Zhuoyu Li
- Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education, Shanxi University, Taiyuan 030006, China
| | - Shuhua Shan
- Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education, Shanxi University, Taiyuan 030006, China
| |
Collapse
|
7
|
Xu P, Yang L, Lai S, Yang F, Kuroda Y, Zhang H, Tsuruta D, Katayama I. Effects of EGFR-TKI on epidermal melanin unit integrity: Therapeutic implications for hypopigmented skin disorders. Pigment Cell Melanoma Res 2024. [PMID: 38705722 DOI: 10.1111/pcmr.13171] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2023] [Revised: 04/15/2024] [Accepted: 04/20/2024] [Indexed: 05/07/2024]
Abstract
Epidermal melanin unit integrity is crucial for skin homeostasis and pigmentation. Epidermal growth factor (EGF) receptor (EGFR) is a pivotal player in cell growth, wound healing, and maintaining skin homeostasis. However, its influence on skin pigmentation is relatively unexplored. This study investigates the impact and underlying mechanisms of EGFR inhibitors on skin pigmentation. We evaluated EGF and EGFR expression in various skin cells using quantitative real-time PCR, Western blot, and immunofluorescence. EGF and EGFR were predominantly expressed in epidermal keratinocytes, and treatment with the EGFR tyrosine kinase inhibitors (EGFR-TKIs) gefitinib and PD153035 significantly increased stem cell factor (SCF) and endothelin-1 (ET-1) expression in cultured keratinocytes. Enhanced melanocyte migration and proliferation were observed in co-culture, as evidenced by time-lapse live imaging and single-cell tracking assays. Furthermore, topical application of gefitinib to guinea pig dorsal skin induced increased pigmentation and demonstrated efficacy in mitigating rhododendrol-induced leukoderma. Suppression of EGF signaling indirectly enhanced skin pigmentation by upregulating SCF and ET-1 in epidermal keratinocytes. This novel mechanism highlights the pivotal role of EGF signaling in regulating skin pigmentation, and topical EGFR-TKI therapy at an appropriate dose may be a promising approach for depigmentation disorder management.
Collapse
Affiliation(s)
- Ping Xu
- Department of Pigmentation Research and Therapeutics, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan
- Department of Dermatology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China
| | - Lingli Yang
- Department of Pigmentation Research and Therapeutics, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan
| | - Sylvia Lai
- Department of Pigmentation Research and Therapeutics, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan
| | - Fei Yang
- Department of Pigmentation Research and Therapeutics, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan
- Biological Science Research Laboratories, Kao Corporation, Odawara, Japan
| | - Yasutaka Kuroda
- Department of Pigmentation Research and Therapeutics, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan
- Biological Science Research Laboratories, Kao Corporation, Odawara, Japan
| | - Huimin Zhang
- Department of Dermatology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China
| | - Daisuke Tsuruta
- Department of Dermatology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan
| | - Ichiro Katayama
- Department of Pigmentation Research and Therapeutics, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan
| |
Collapse
|
8
|
Zhang H, Jia C, Xiao Y, Zhang J, Yu J, Li X, Hamid N, Sun A. Enhanced stability and bioavailability of mulberry anthocyanins through the development of sodium caseinate-konjac glucomannan nanoparticles. Food Chem 2024; 439:138150. [PMID: 38100879 DOI: 10.1016/j.foodchem.2023.138150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2023] [Revised: 11/23/2023] [Accepted: 12/03/2023] [Indexed: 12/17/2023]
Abstract
This study was carried out to improve the stability of anthocyanins (ACNs) by developing MA-SC-KGM nanoparticles using a self-assembly method that involved the combination of sodium caseinate (SC) and konjac glucomannan (KGM) with mulberry anthocyanin extract (MA). Atomic force microscopy (AFM) analysis showed SC encapsulated MA successfully. Multispectral techniques demonstrated the presence of hydrogen bonds and hydrophobic interactions in the nanoparticles. MA-SC-KGM ternary mixture improved storage stability, color stability and anthocyanin retention better compared to the MA-SC binary mixture. Notably, MA-SC-KGM nanoparticles significantly inhibited the thermal degradation of ACNs, improved pH stability, and showed stability and a slow-release effect in gastrointestinal digestion experiments. In addition, MA-SC-KGM nanoparticles were effective in scavenging DPPH· and ABTS+ free radicals, with enhanced stability and antioxidant capacity even during the heating process. This study successfully developed a novel MA-SC-KGM protein-polysaccharide composite material that effectively stabilized natural ACNs, expanding the application of ACNs in various industries.
Collapse
Affiliation(s)
- Huimin Zhang
- College of Biological Science and Technology, Beijing Key Laboratory of Forest Food Processing and Safety, Beijing Forestry University, Beijing 100091, China
| | - Chengli Jia
- College of Biological Science and Technology, Beijing Key Laboratory of Forest Food Processing and Safety, Beijing Forestry University, Beijing 100091, China
| | - Yuhang Xiao
- College of Biological Science and Technology, Beijing Key Laboratory of Forest Food Processing and Safety, Beijing Forestry University, Beijing 100091, China
| | - Jingyue Zhang
- College of Biological Science and Technology, Beijing Key Laboratory of Forest Food Processing and Safety, Beijing Forestry University, Beijing 100091, China
| | - Jingwen Yu
- College of Biological Science and Technology, Beijing Key Laboratory of Forest Food Processing and Safety, Beijing Forestry University, Beijing 100091, China
| | - Xinran Li
- College of Biological Science and Technology, Beijing Key Laboratory of Forest Food Processing and Safety, Beijing Forestry University, Beijing 100091, China
| | - Nazimah Hamid
- Department of Food Science, Auckland University of Technology, Private Bag 92006, Auckland 1142, New Zealand
| | - Aidong Sun
- College of Biological Science and Technology, Beijing Key Laboratory of Forest Food Processing and Safety, Beijing Forestry University, Beijing 100091, China.
| |
Collapse
|
9
|
Zhang L, Yuan L, Wen Y, Zhang M, Huang S, Wang S, Zhao Y, Hao X, Li L, Gao Q, Wang Y, Zhang S, Huang S, Liu K, Yu X, Li D, Xu J, Zhao B, Zhang L, Zhang H, Zhou W, Ai C. Maize functional requirements drive the selection of rhizobacteria under long-term fertilization practices. New Phytol 2024; 242:1275-1288. [PMID: 38426620 DOI: 10.1111/nph.19653] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/06/2023] [Accepted: 02/14/2024] [Indexed: 03/02/2024]
Abstract
Rhizosphere microbiomes are pivotal for crop fitness, but the principles underlying microbial assembly during root-soil interactions across soils with different nutrient statuses remain elusive. We examined the microbiomes in the rhizosphere and bulk soils of maize plants grown under six long-term (≥ 29 yr) fertilization experiments in three soil types across middle temperate to subtropical zones. The assembly of rhizosphere microbial communities was primarily driven by deterministic processes. Plant selection interacted with soil types and fertilization regimes to shape the structure and function of rhizosphere microbiomes. Predictive functional profiling showed that, to adapt to nutrient-deficient conditions, maize recruited more rhizobacteria involved in nutrient availability from bulk soil, although these functions were performed by different species. Metagenomic analyses confirmed that the number of significantly enriched Kyoto Encyclopedia of Genes and Genomes Orthology functional categories in the rhizosphere microbial community was significantly higher without fertilization than with fertilization. Notably, some key genes involved in carbon, nitrogen, and phosphorus cycling and purine metabolism were dominantly enriched in the rhizosphere soil without fertilizer input. In conclusion, our results show that maize selects microbes at the root-soil interface based on microbial functional traits beneficial to its own performance, rather than selecting particular species.
Collapse
Affiliation(s)
- Liyu Zhang
- State Key Laboratory of Efficient Utilization of Arid and Semi-arid Arable Land in Northern China, The Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences, Beijing, 100081, China
- Key Laboratory of Plant Nutrition and Fertilizer, Ministry of Agriculture and Rural Affairs, Beijing, 100081, China
| | - Liang Yuan
- State Key Laboratory of Efficient Utilization of Arid and Semi-arid Arable Land in Northern China, The Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences, Beijing, 100081, China
- Key Laboratory of Plant Nutrition and Fertilizer, Ministry of Agriculture and Rural Affairs, Beijing, 100081, China
| | - Yanchen Wen
- State Key Laboratory of Efficient Utilization of Arid and Semi-arid Arable Land in Northern China, The Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences, Beijing, 100081, China
- Key Laboratory of Plant Nutrition and Fertilizer, Ministry of Agriculture and Rural Affairs, Beijing, 100081, China
| | - Meiling Zhang
- State Key Laboratory of Efficient Utilization of Arid and Semi-arid Arable Land in Northern China, The Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences, Beijing, 100081, China
- Key Laboratory of Plant Nutrition and Fertilizer, Ministry of Agriculture and Rural Affairs, Beijing, 100081, China
| | - Shuyu Huang
- State Key Laboratory of Efficient Utilization of Arid and Semi-arid Arable Land in Northern China, The Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences, Beijing, 100081, China
- Key Laboratory of Plant Nutrition and Fertilizer, Ministry of Agriculture and Rural Affairs, Beijing, 100081, China
| | - Shiyu Wang
- State Key Laboratory of Efficient Utilization of Arid and Semi-arid Arable Land in Northern China, The Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences, Beijing, 100081, China
- Key Laboratory of Plant Nutrition and Fertilizer, Ministry of Agriculture and Rural Affairs, Beijing, 100081, China
| | - Yuanzheng Zhao
- State Key Laboratory of Efficient Utilization of Arid and Semi-arid Arable Land in Northern China, The Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences, Beijing, 100081, China
- Key Laboratory of Plant Nutrition and Fertilizer, Ministry of Agriculture and Rural Affairs, Beijing, 100081, China
| | - Xiangxiang Hao
- Hailun National Observation and Research Station of Agroecosystems, Key Laboratory of Mollisols Agroecology, Northeast Institute of Geography and Agroecology, Chinese Academy of Sciences, Harbin, 150081, China
| | - Lujun Li
- Hailun National Observation and Research Station of Agroecosystems, Key Laboratory of Mollisols Agroecology, Northeast Institute of Geography and Agroecology, Chinese Academy of Sciences, Harbin, 150081, China
| | - Qiang Gao
- Jilin Agricultural University, Changchun, 130118, China
| | - Yin Wang
- Jilin Agricultural University, Changchun, 130118, China
| | - Shuiqing Zhang
- Institute of Plant Nutrition, Resource and Environment, Henan Academy of Agricultural Sciences, 116 Garden Road, Zhengzhou, 450002, China
| | - Shaomin Huang
- Institute of Plant Nutrition, Resource and Environment, Henan Academy of Agricultural Sciences, 116 Garden Road, Zhengzhou, 450002, China
| | - Kailou Liu
- Jiangxi Institute of Red Soil, National Engineering and Technology Research Center for Red Soil Improvement, Nanchang, 330046, China
| | - Xichu Yu
- Jiangxi Institute of Red Soil, National Engineering and Technology Research Center for Red Soil Improvement, Nanchang, 330046, China
| | - Dongchu Li
- State Key Laboratory of Efficient Utilization of Arid and Semi-arid Arable Land in Northern China, The Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences, Beijing, 100081, China
| | - Jiukai Xu
- State Key Laboratory of Efficient Utilization of Arid and Semi-arid Arable Land in Northern China, The Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences, Beijing, 100081, China
- Key Laboratory of Plant Nutrition and Fertilizer, Ministry of Agriculture and Rural Affairs, Beijing, 100081, China
| | - Bingqiang Zhao
- State Key Laboratory of Efficient Utilization of Arid and Semi-arid Arable Land in Northern China, The Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences, Beijing, 100081, China
- Key Laboratory of Plant Nutrition and Fertilizer, Ministry of Agriculture and Rural Affairs, Beijing, 100081, China
| | - Lu Zhang
- State Key Laboratory of Efficient Utilization of Arid and Semi-arid Arable Land in Northern China, The Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences, Beijing, 100081, China
| | - Huimin Zhang
- State Key Laboratory of Efficient Utilization of Arid and Semi-arid Arable Land in Northern China, The Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences, Beijing, 100081, China
| | - Wei Zhou
- State Key Laboratory of Efficient Utilization of Arid and Semi-arid Arable Land in Northern China, The Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences, Beijing, 100081, China
- Key Laboratory of Plant Nutrition and Fertilizer, Ministry of Agriculture and Rural Affairs, Beijing, 100081, China
| | - Chao Ai
- State Key Laboratory of Efficient Utilization of Arid and Semi-arid Arable Land in Northern China, The Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences, Beijing, 100081, China
- Key Laboratory of Plant Nutrition and Fertilizer, Ministry of Agriculture and Rural Affairs, Beijing, 100081, China
| |
Collapse
|
10
|
Cui Y, Ran R, Da Y, Zhang H, Jiang M, Qi X, Zhang W, Niu L, Zhou Y, Zhou C, Tang X, Wang K, Yan Y, Ren Y, Dong D, Zhou Y, Wang H, Gong J, Hu F, Zhao S, Zhang H, Zhang C, Yang J. The combination of breast cancer PDO and mini-PDX platform for drug screening and individualized treatment. J Cell Mol Med 2024; 28:e18374. [PMID: 38722288 PMCID: PMC11081008 DOI: 10.1111/jcmm.18374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2023] [Revised: 03/05/2024] [Accepted: 04/16/2024] [Indexed: 05/12/2024] Open
Abstract
The majority of advanced breast cancers exhibit strong aggressiveness, heterogeneity, and drug resistance, and currently, the lack of effective treatment strategies is one of the main challenges that cancer research must face. Therefore, developing a feasible preclinical model to explore tailored treatments for refractory breast cancer is urgently needed. We established organoid biobanks from 17 patients with breast cancer and characterized them by immunohistochemistry (IHC) and next generation sequencing (NGS). In addition, we in the first combination of patient-derived organoids (PDOs) with mini-patient-derived xenografts (Mini-PDXs) for the rapid and precise screening of drug sensitivity. We confirmed that breast cancer organoids are a high-fidelity three-dimension (3D) model in vitro that recapitulates the original tumour's histological and genetic features. In addition, for a heavily pretreated patient with advanced drug-resistant breast cancer, we combined PDO and Mini-PDX models to identify potentially effective combinations of therapeutic agents for this patient who were alpelisib + fulvestrant. In the drug sensitivity experiment of organoids, we observed changes in the PI3K/AKT/mTOR signalling axis and oestrogen receptor (ER) protein expression levels, which further verified the reliability of the screening results. Our study demonstrates that the PDO combined with mini-PDX model offers a rapid and precise drug screening platform that holds promise for personalized medicine, improving patient outcomes and addressing the urgent need for effective therapies in advanced breast cancer.
Collapse
Affiliation(s)
- Yuxin Cui
- Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
- Cancer Center, The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
- Department of Medical OncologyThe First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
| | - Ran Ran
- Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
- Cancer Center, The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
- Department of Medical OncologyThe First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
| | - Yanyan Da
- Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
- Center for Molecular Diagnosis and Precision MedicineThe First Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityNanchangJiangxiChina
| | - Huiwen Zhang
- Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
| | - Meng Jiang
- Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
- Cancer Center, The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
- Department of Medical OncologyThe First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
| | - Xin Qi
- Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
- Cancer Center, The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
- Department of Medical OncologyThe First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
| | - Wei Zhang
- Department of Breast SurgeryThe First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
| | - Ligang Niu
- Department of Breast SurgeryThe First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
| | - Yuhui Zhou
- Department of Breast SurgeryThe First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
| | - Can Zhou
- Department of Breast SurgeryThe First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
| | - Xiaojiang Tang
- Department of Breast SurgeryThe First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
| | - Ke Wang
- Department of Breast SurgeryThe First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
| | - Yu Yan
- Department of Breast SurgeryThe First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
| | - Yu Ren
- Department of Breast SurgeryThe First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
| | - Danfeng Dong
- Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
- Cancer Center, The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
- Department of Medical OncologyThe First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
| | - Yan Zhou
- Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
- Cancer Center, The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
- Department of Medical OncologyThe First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
| | - Hui Wang
- Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
- Cancer Center, The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
- Department of Medical OncologyThe First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
| | - Jin Gong
- Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
- Cancer Center, The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
- Department of Medical OncologyThe First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
| | - Fang Hu
- Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
- Cancer Center, The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
- Department of Medical OncologyThe First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
| | - Shidi Zhao
- Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
- Cancer Center, The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
- Department of Medical OncologyThe First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
| | - Huimin Zhang
- Department of Breast SurgeryThe First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
| | - Chengsheng Zhang
- Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
- Cancer Center, The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
- Center for Molecular Diagnosis and Precision MedicineThe First Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityNanchangJiangxiChina
| | - Jin Yang
- Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
- Cancer Center, The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
- Department of Medical OncologyThe First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxiPeople's Republic of China
| |
Collapse
|
11
|
Sun J, Zhou N, Zhang H, Wu H, Wang F, Luo Y. Longitudinal analysis of the mediating role of self-perception of aging in the relationship between frailty and intrinsic capacity: A cross-lagged mediation model. Arch Gerontol Geriatr 2024; 120:105336. [PMID: 38301318 DOI: 10.1016/j.archger.2024.105336] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2023] [Revised: 01/06/2024] [Accepted: 01/18/2024] [Indexed: 02/03/2024]
Abstract
OBJECTIVES The causal relationship between intrinsic capacity and frailty in older adults, as well as the underlying temporal mechanisms, remained poorly understood. The study aimed to investigate the causal association between intrinsic capacity and frailty while exploring the potential mediating role of self-perception of aging. MEASUREMENTS A survey was conducted with a sample of 429 participants who completed measures of intrinsic capacity, self-perception of aging, and frailty at baseline and were followed for one year. The relationships between these variables were assessed using an autoregressive cross-lagged model. RESULTS The study found reciprocal associations between intrinsic capacity and frailty (p < 0.01). Furthermore, the results indicated that self-perception of aging partially mediated the effect of frailty at baseline (T1) on intrinsic capacity at one-year follow-up (T2) (β = -0.02, confidence interval: [-0.055, -0.004]). However, the reverse causation was not observed. CONCLUSIONS AND IMPLICATIONS This study demonstrates a bidirectional causal relationship between intrinsic capacity and frailty in older adults. Self-perception of aging plays a significant mediating role in this relationship. Older adults with a worse level of frailty should be made aware of the potentially vicious cycle related to self-perception of aging, which can negatively affect their intrinsic capacity. Maintaining a positive self-perception of aging may help preserve physical and psychological reserves, maintain intrinsic capacity, and slow the decline of frailty.
Collapse
Affiliation(s)
- Junjun Sun
- School of Nursing, Xinxiang Medical University, Xinxiang, China
| | - Ning Zhou
- School of Nursing, Xinxiang Medical University, Xinxiang, China
| | - Huimin Zhang
- School of Nursing, Xinxiang Medical University, Xinxiang, China
| | - Huimin Wu
- School of Nursing, Xinxiang Medical University, Xinxiang, China
| | - Feifei Wang
- School of Nursing, Xinxiang Medical University, Xinxiang, China
| | - Yanyan Luo
- School of Nursing, Xinxiang Medical University, Xinxiang, China.
| |
Collapse
|
12
|
Chi R, Zhang H, Li H, Huang B, Hou Z. Data-Driven Dynamic Internal Model Control. IEEE Trans Cybern 2024; PP:1-13. [PMID: 38687667 DOI: 10.1109/tcyb.2024.3387409] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/02/2024]
Abstract
A data-driven dynamic internal model control (D 3 IMC) scheme is proposed for unknown nonlinear nonaffine systems bypassing modeling steps. Different from the traditional internal model constructed by either a first-principle or an identified model, a dynamic internal model (DIM) is developed in this work using I/O data where a compact form dynamic linearization approach is introduced for addressing the nonlinearity and nonaffine structure. Then, the D 3 IMC is proposed with both a nominal control algorithm and an uncertainty compensation control algorithm. The former can quickly respond to the feedback errors and the latter can compensate the model-plant mismatch and external disturbances. Meanwhile, the adaptive parameter updating law in the proposed D 3 IMC method inherits the robustness against uncertainties. A nominal D 3 IMC is also designed without including the compensator when there is no exogenous disturbance since the adaptive mechanism can handle system uncertainty. Further, the results are extended and a full-form dynamic linearization-based D 3 IMC is developed to address control of nonlinear systems with more complex dynamics. All the proposed D 3 IMC methods are data-driven without need of an explicit model, and thus they are significant extensions from the traditional model-based IMC. Simulation study verifies the results.
Collapse
|
13
|
Hu X, Hu C, Liao L, Zhang H, Xu X, Xiang J, Lu G, Jia X, Xu H, Gong W. Isoliquiritigenin limits inflammasome activation of macrophage via docking into Syk to alleviate murine non-alcoholic fatty liver disease. Scand J Immunol 2024:e13371. [PMID: 38671579 DOI: 10.1111/sji.13371] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2023] [Revised: 03/22/2024] [Accepted: 04/05/2024] [Indexed: 04/28/2024]
Abstract
Isoliquiritigenin (ISL) is a chalcone-type flavonoid derived from the root of licorice with antioxidant, anti-inflammatory, anti-tumour and neuroprotective properties. ISL has been proven to downregulate the productions of IL-1β, TNF-α and IL-6 by macrophages. However, detailed molecular mechanisms of this modulation remain elusive. Here, ISL suppressed Syk phosphorylation and CD80, CD86, IL-1β, TNF-α and IL-6 expressions in lipopolysaccharide-stimulated macrophages ex vivo. ApoC3-transgenic (ApoC3TG) mice had more activated macrophages. ISL was also able to downregulate the inflammatory activities of macrophages from ApoC3TG mice. Administration of ISL inhibited Syk activation and inflammatory activities of macrophages in ApoC3TG mice in vivo. The treatment of ISL further alleviated MCD-induced non-alcoholic fatty liver disease (NAFLD) in wild-type and ApoC3TG mice, accompanied by less recruitment and activation of liver macrophages. Due to the inhibition of Syk phosphorylation, ISL-treated macrophages displayed less production of cytoplasmic ROS, NLRP3, cleaved-GSDMD and cleaved-IL-1β, suggesting less inflammasome activation. Finally, the molecular docking study demonstrated that ISL bound to Syk directly with the Kd of 1.273 × 10-8 M. When the Syk expression was knocked down by its shRNA, the inhibitory effects of ISL on activated macrophages disappeared, indicating that Syk was at least one of key docking-molecules of ISL. Collectively, ISL could alleviate MCD-induced NAFLD in mice involved with the inhibition of macrophage inflammatory activity by the blockade of Syk-induced inflammasome activation.
Collapse
Affiliation(s)
- Xiangyu Hu
- Department of Gastroenterology, Yangzhou Key Laboratory for Precision Treatment of Refractory Bowel Diseases, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China
- Department of Basic Medicine, School of Medicine, Yangzhou University, Yangzhou, China
| | - Chunmiao Hu
- Department of Basic Medicine, School of Medicine, Yangzhou University, Yangzhou, China
| | - Liting Liao
- Department of Basic Medicine, School of Medicine, Yangzhou University, Yangzhou, China
| | - Huimin Zhang
- Department of Basic Medicine, School of Medicine, Yangzhou University, Yangzhou, China
| | - Xingmeng Xu
- Department of Gastroenterology, Yangzhou Key Laboratory for Precision Treatment of Refractory Bowel Diseases, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China
| | - Jie Xiang
- Department of Pharmacology, School of Medicine, Yangzhou University, Yangzhou, China
| | - Guotao Lu
- Department of Gastroenterology, Yangzhou Key Laboratory for Precision Treatment of Refractory Bowel Diseases, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China
- Department of Gastroenterology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China
| | - Xiaoqin Jia
- Department of Basic Medicine, School of Medicine, Yangzhou University, Yangzhou, China
| | - Hongwei Xu
- Kunshan Hospital of Traditional Chinese Medicine, Kunshan Affiliated Hospital of Yangzhou University, Kunshan, China
| | - Weijuan Gong
- Department of Gastroenterology, Yangzhou Key Laboratory for Precision Treatment of Refractory Bowel Diseases, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China
- Department of Basic Medicine, School of Medicine, Yangzhou University, Yangzhou, China
- Department of Gastroenterology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China
- Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou, China
- Jiangsu Key Laboratory of Zoonosis, Yangzhou, China
| |
Collapse
|
14
|
Zhang H, Qiu J, Pang J, Cao G, Zhang B, Wang L, He X, Feng X, Ma S, Zhang X, Ming H, Li Z, Li F, Zhang H. Sub-millisecond lithiothermal synthesis of graphitic meso-microporous carbon. Nat Commun 2024; 15:3491. [PMID: 38664439 PMCID: PMC11045851 DOI: 10.1038/s41467-024-47916-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2023] [Accepted: 04/11/2024] [Indexed: 04/28/2024] Open
Abstract
Porous carbons with concurrently high specific surface area and electronic conductivity are desirable by virtue of their desirable electron and ion transport ability, but conventional preparing methods suffer from either low yield or inferior quality carbons. Here we developed a lithiothermal approach to bottom-up synthesize highly meso-microporous graphitized carbon (MGC). The preparation can be finished in a few milliseconds by the self-propagating reaction between polytetrafluoroethylene powder and molten lithium (Li) metal, during which instant ultra-high temperature (>3000 K) was produced. This instantaneous carbon vaporization and condensation at ultra-high temperatures and in ultra-short duration enable the MGC to show a highly graphitized and continuously cross-coupled open pore structure. MGC displays superior electrochemical capacitor performance of exceptional power capability and ultralong-term cyclability. The processes used to make this carbon are readily scalable to industrial levels.
Collapse
Affiliation(s)
- Huimin Zhang
- Beijing Key Laboratory of Advanced Chemical Energy Storage Technologies and Materials, Research Institute of Chemical Defense, Beijing, China
| | - Jingyi Qiu
- Beijing Key Laboratory of Advanced Chemical Energy Storage Technologies and Materials, Research Institute of Chemical Defense, Beijing, China
| | - Jie Pang
- School of Energy Science and Technology, Henan University, Zhengzhou, China
| | - Gaoping Cao
- Beijing Key Laboratory of Advanced Chemical Energy Storage Technologies and Materials, Research Institute of Chemical Defense, Beijing, China
| | - Bingsen Zhang
- Shenyang National Laboratory for Materials Science, Institute of Metal Research, Chinese Academy of Sciences, Shenyang, China
| | - Li Wang
- Institute of Nuclear and New Energy Technology, Tsinghua University, Beijing, China
| | - Xiangming He
- Institute of Nuclear and New Energy Technology, Tsinghua University, Beijing, China
| | - Xuning Feng
- Institute of Nuclear and New Energy Technology, Tsinghua University, Beijing, China
| | - Shizhou Ma
- Beijing Key Laboratory of Advanced Chemical Energy Storage Technologies and Materials, Research Institute of Chemical Defense, Beijing, China
| | - Xinggao Zhang
- Beijing Key Laboratory of Advanced Chemical Energy Storage Technologies and Materials, Research Institute of Chemical Defense, Beijing, China
| | - Hai Ming
- Beijing Key Laboratory of Advanced Chemical Energy Storage Technologies and Materials, Research Institute of Chemical Defense, Beijing, China
| | - Zhuangnan Li
- Department of Material Science and Metallurgy, University of Cambridge, Cambridge, UK
| | - Feng Li
- Shenyang National Laboratory for Materials Science, Institute of Metal Research, Chinese Academy of Sciences, Shenyang, China.
| | - Hao Zhang
- Beijing Key Laboratory of Advanced Chemical Energy Storage Technologies and Materials, Research Institute of Chemical Defense, Beijing, China.
| |
Collapse
|
15
|
Hegde M, Navai S, DeRenzo C, Joseph SK, Sanber K, Wu M, Gad AZ, Janeway KA, Campbell M, Mullikin D, Nawas Z, Robertson C, Mathew PR, Zhang H, Mehta B, Bhat RR, Major A, Shree A, Gerken C, Kalra M, Chakraborty R, Thakkar SG, Dakhova O, Salsman VS, Grilley B, Lapteva N, Gee A, Dotti G, Bao R, Salem AH, Wang T, Brenner MK, Heslop HE, Wels WS, Hicks MJ, Gottschalk S, Ahmed N. Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial. Nat Cancer 2024:10.1038/s43018-024-00749-6. [PMID: 38658775 DOI: 10.1038/s43018-024-00749-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/23/2022] [Accepted: 02/23/2024] [Indexed: 04/26/2024]
Abstract
In this prospective, interventional phase 1 study for individuals with advanced sarcoma, we infused autologous HER2-specific chimeric antigen receptor T cells (HER2 CAR T cells) after lymphodepletion with fludarabine (Flu) ± cyclophosphamide (Cy): 1 × 108 T cells per m2 after Flu (cohort A) or Flu/Cy (cohort B) and 1 × 108 CAR+ T cells per m2 after Flu/Cy (cohort C). The primary outcome was assessment of safety of one dose of HER2 CAR T cells after lymphodepletion. Determination of antitumor responses was the secondary outcome. Thirteen individuals were treated in 14 enrollments, and seven received multiple infusions. HER2 CAR T cells expanded after 19 of 21 infusions. Nine of 12 individuals in cohorts A and B developed grade 1-2 cytokine release syndrome. Two individuals in cohort C experienced dose-limiting toxicity with grade 3-4 cytokine release syndrome. Antitumor activity was observed with clinical benefit in 50% of individuals treated. The tumor samples analyzed showed spatial heterogeneity of immune cells and clustering by sarcoma type and by treatment response. Our results affirm HER2 as a CAR T cell target and demonstrate the safety of this therapeutic approach in sarcoma. ClinicalTrials.gov registration: NCT00902044 .
Collapse
Affiliation(s)
- Meenakshi Hegde
- Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.
- Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
- Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.
| | - Shoba Navai
- Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA
- Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA
- Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA
| | - Christopher DeRenzo
- Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA
- Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA
- Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA
| | - Sujith K Joseph
- Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA
- Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA
- Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA
| | - Khaled Sanber
- Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA
- Department of Medicine, Baylor College of Medicine, Houston, TX, USA
| | - Mengfen Wu
- Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA
| | - Ahmed Z Gad
- Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA
- Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA
- Interdepartmental Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, TX, USA
| | - Katherine A Janeway
- Department of Pediatrics, Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
| | - Matthew Campbell
- Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA
- Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA
| | - Dolores Mullikin
- Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA
- Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA
| | - Zeid Nawas
- Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA
- Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA
| | - Catherine Robertson
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA
| | - Pretty R Mathew
- Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA
- Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA
| | - Huimin Zhang
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA
| | - Birju Mehta
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA
| | - Raksha R Bhat
- Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA
- Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA
| | - Angela Major
- Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA
| | - Ankita Shree
- Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA
- Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA
| | - Claudia Gerken
- Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA
- Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA
| | - Mamta Kalra
- Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA
- Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA
| | - Rikhia Chakraborty
- Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA
- Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA
- Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA
| | - Sachin G Thakkar
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA
| | - Olga Dakhova
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA
| | - Vita S Salsman
- Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA
- Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA
| | - Bambi Grilley
- Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA
- Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA
- Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA
| | - Natalia Lapteva
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA
- Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA
| | - Adrian Gee
- Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA
- Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA
| | - Gianpietro Dotti
- Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - Riyue Bao
- Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
- UPMC Hillman Cancer Center, Pittsburgh, PA, USA
| | | | - Tao Wang
- Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA
| | - Malcolm K Brenner
- Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA
- Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA
- Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA
- Department of Medicine, Baylor College of Medicine, Houston, TX, USA
| | - Helen E Heslop
- Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA
- Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA
- Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA
- Department of Medicine, Baylor College of Medicine, Houston, TX, USA
| | - Winfried S Wels
- Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany
- German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany
- Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany
| | - M John Hicks
- Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA
- Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA
| | - Stephen Gottschalk
- Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA
- Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA
- Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA
- Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA
| | - Nabil Ahmed
- Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.
- Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
- Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.
- Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.
| |
Collapse
|
16
|
Wang R, Wang B, Zhang H, Liao X, Shi B, Zhou Y, Zhou C, Yan Y, Zhang W, Wang K, Ge G, Ren Y, Tang X, Gan B, He J, Niu L. Early evaluation of circulating tumor DNA as marker of therapeutic efficacy and prognosis in breast cancer patients during primary systemic therapy. Breast 2024; 76:103738. [PMID: 38685149 PMCID: PMC11067540 DOI: 10.1016/j.breast.2024.103738] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2024] [Revised: 04/17/2024] [Accepted: 04/23/2024] [Indexed: 05/02/2024] Open
Abstract
BACKGROUND We assessed the potential role of serial circulating tumor DNA (ctDNA) as a biomarker to monitor treatment response to primary systemic therapy (PST) in breast cancer and evaluated the predictive value of ctDNA to further identify patients with residual disease. METHODS We prospectively enrolled 208 plasma samples collected at three time points (before PST, after 2 cycles of treatment, before surgery) of 72 patients with stage Ⅱ-III breast cancer. Somatic mutations in plasma samples were identified using a customized 128-gene capture panel with next-generation sequencing. The correlation between early change in ctDNA levels and treatment response or long-term clinical outcomes was assessed. RESULTS 37 of 72 (51.4%) patients harbored detectable ctDNA alterations at baseline. Patients with complete response showed a larger decrease in ctDNA levels during PST. The median relative change of variant allele fraction (VAF) was -97.4%, -46.7%, and +21.1% for patients who subsequently had a complete response (n = 11), partial response (n = 11), and no response (n = 15) (p = 0.0012), respectively. In addition, the relative change of VAF between the pretreatment and first on-treatment blood draw exhibited the optimal predictive value to tumor response after PST (area under the curve, AUC = 0.7448, p = 0.02). More importantly, early change of ctDNA levels during treatment have significant prognostic value for patients with BC, there was a significant correlation between early decrease of VAF and longer recurrence-free survival compared to those with an VAF increase (HR = 12.54; 95% CI, 2.084 to 75.42, p = 0.0063). CONCLUSION Early changes of ctDNA are strongly correlated with therapeutic efficacy to PST and clinical outcomes in BC patients. The integration of preoperative ctDNA evaluation could help improving the perioperative management for BC patients receiving PST.
Collapse
Affiliation(s)
- Ru Wang
- Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China
| | - Bin Wang
- Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China
| | - Huimin Zhang
- Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China
| | - Xiaoqin Liao
- Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China
| | - Bohui Shi
- Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China
| | - Yuhui Zhou
- Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China
| | - Can Zhou
- Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China
| | - Yu Yan
- Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China
| | - Wei Zhang
- Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China
| | - Ke Wang
- Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China
| | - Guanqun Ge
- Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China
| | - Yu Ren
- Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China
| | - Xiaojiang Tang
- Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China
| | - Baoyu Gan
- Biobank of the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China
| | - Jianjun He
- Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.
| | - Ligang Niu
- Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.
| |
Collapse
|
17
|
Yin K, Zhao M, Xu Y, Zheng Z, Huang S, Liang D, Dong H, Guo Y, Lin L, Song J, Zhang H, Zheng J, Zhu Z, Yang C. Well-Paired-Seq2: High-Throughput and High-Sensitivity Strategy for Characterizing Low RNA-Content Cell/Nucleus Transcriptomes. Anal Chem 2024; 96:6301-6310. [PMID: 38597061 DOI: 10.1021/acs.analchem.3c05785] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/11/2024]
Abstract
Single-cell RNA sequencing (scRNA-seq) is a transformative technology that unravels the intricate cellular state heterogeneity. However, the Poisson-dependent cell capture and low sensitivity in scRNA-seq methods pose challenges for throughput and samples with a low RNA-content. Herein, to address these challenges, we present Well-Paired-Seq2 (WPS2), harnessing size-exclusion and quasi-static hydrodynamics for efficient cell capture. WPS2 exploits molecular crowding effect, tailing activity enhancement in reverse transcription, and homogeneous enzymatic reaction in the initial bead-based amplification to achieve 3116 genes and 8447 transcripts with an average of ∼20000 reads per cell. WPS2 detected 1420 more genes and 4864 more transcripts than our previous Well-Paired-Seq. It sensitively characterizes transcriptomes of low RNA-content single cells and nuclei, overcoming the Poisson limit for cell and barcoded bead capture. WPS2 also profiles transcriptomes from frozen clinical samples, revealing heterogeneous tumor copy number variations and intercellular crosstalk in clear cell renal cell carcinomas. Additionally, we provide the first single-cell-level characterization of rare metanephric adenoma (MA) and uncover potential specific markers. With the advantages of high sensitivity and high throughput, WPS2 holds promise for diverse basic and clinical research.
Collapse
Affiliation(s)
- Kun Yin
- State Key Laboratory of Physical Chemistry of Solid Surfaces, The MOE Key Laboratory of Spectrochemical Analysis & Instrumentation, Key Laboratory for Chemical Biology of Fujian Province, Collaborative Innovation Center of Chemistry for Energy Materials, Department of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, P. R. China
- Institute of Molecular Medicine, State Key Laboratory of Oncogenes and Related Genes, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200120, China
| | - Meijuan Zhao
- State Key Laboratory of Physical Chemistry of Solid Surfaces, The MOE Key Laboratory of Spectrochemical Analysis & Instrumentation, Key Laboratory for Chemical Biology of Fujian Province, Collaborative Innovation Center of Chemistry for Energy Materials, Department of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, P. R. China
| | - Yiling Xu
- State Key Laboratory of Physical Chemistry of Solid Surfaces, The MOE Key Laboratory of Spectrochemical Analysis & Instrumentation, Key Laboratory for Chemical Biology of Fujian Province, Collaborative Innovation Center of Chemistry for Energy Materials, Department of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, P. R. China
| | - Zhong Zheng
- Institute of Molecular Medicine, State Key Laboratory of Oncogenes and Related Genes, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200120, China
| | - Shanqing Huang
- State Key Laboratory of Physical Chemistry of Solid Surfaces, The MOE Key Laboratory of Spectrochemical Analysis & Instrumentation, Key Laboratory for Chemical Biology of Fujian Province, Collaborative Innovation Center of Chemistry for Energy Materials, Department of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, P. R. China
| | - Dianyi Liang
- State Key Laboratory of Physical Chemistry of Solid Surfaces, The MOE Key Laboratory of Spectrochemical Analysis & Instrumentation, Key Laboratory for Chemical Biology of Fujian Province, Collaborative Innovation Center of Chemistry for Energy Materials, Department of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, P. R. China
| | - He Dong
- State Key Laboratory of Physical Chemistry of Solid Surfaces, The MOE Key Laboratory of Spectrochemical Analysis & Instrumentation, Key Laboratory for Chemical Biology of Fujian Province, Collaborative Innovation Center of Chemistry for Energy Materials, Department of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, P. R. China
| | - Ye Guo
- State Key Laboratory of Physical Chemistry of Solid Surfaces, The MOE Key Laboratory of Spectrochemical Analysis & Instrumentation, Key Laboratory for Chemical Biology of Fujian Province, Collaborative Innovation Center of Chemistry for Energy Materials, Department of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, P. R. China
| | - Li Lin
- State Key Laboratory of Physical Chemistry of Solid Surfaces, The MOE Key Laboratory of Spectrochemical Analysis & Instrumentation, Key Laboratory for Chemical Biology of Fujian Province, Collaborative Innovation Center of Chemistry for Energy Materials, Department of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, P. R. China
| | - Jia Song
- Institute of Molecular Medicine, State Key Laboratory of Oncogenes and Related Genes, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200120, China
| | - Huimin Zhang
- Innovation Laboratory for Sciences and Technologies of Energy Materials of Fujian Province (IKKEM), Xiamen 361005, China
| | - Junhua Zheng
- Institute of Molecular Medicine, State Key Laboratory of Oncogenes and Related Genes, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200120, China
| | - Zhi Zhu
- State Key Laboratory of Physical Chemistry of Solid Surfaces, The MOE Key Laboratory of Spectrochemical Analysis & Instrumentation, Key Laboratory for Chemical Biology of Fujian Province, Collaborative Innovation Center of Chemistry for Energy Materials, Department of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, P. R. China
| | - Chaoyong Yang
- State Key Laboratory of Physical Chemistry of Solid Surfaces, The MOE Key Laboratory of Spectrochemical Analysis & Instrumentation, Key Laboratory for Chemical Biology of Fujian Province, Collaborative Innovation Center of Chemistry for Energy Materials, Department of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, P. R. China
- Institute of Molecular Medicine, State Key Laboratory of Oncogenes and Related Genes, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200120, China
- Innovation Laboratory for Sciences and Technologies of Energy Materials of Fujian Province (IKKEM), Xiamen 361005, China
| |
Collapse
|
18
|
Zhang H, Xu D, Huang H, Jiang H, Hu L, Liu L, Sun G, Gao J, Li Y, Xia C, Chen S, Zhou H, Kong X, Wang M, Luo C. Discovery of a Covalent Inhibitor Selectively Targeting the Autophosphorylation Site of c-Src Kinase. ACS Chem Biol 2024; 19:999-1010. [PMID: 38513196 DOI: 10.1021/acschembio.4c00048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/23/2024]
Abstract
Nonreceptor tyrosine kinase c-Src plays a crucial role in cell signaling and contributes to tumor progression. However, the development of selective c-Src inhibitors turns out to be challenging. In our previous study, we performed posttranslational modification-inspired drug design (PTMI-DD) to provide a plausible way for designing selective kinase inhibitors. In this study, after identifying a unique pocket comprising a less conserved cysteine and an autophosphorylation site in c-Src as well as a promiscuous covalent inhibitor, chemical optimization was performed to obtain (R)-LW-Srci-8 with nearly 75-fold improved potency (IC50 = 35.83 ± 7.21 nM). Crystallographic studies revealed the critical C-F···C═O interactions that may contribute to tight binding. The kinact and Ki values validated the improved binding affinity and decreased warhead reactivity of (R)-LW-Srci-8 for c-Src. Notably, in vitro tyrosine kinase profiling and cellular activity-based protein profiling (ABPP) cooperatively indicated a specific inhibition of c-Src by (R)-LW-Srci-8. Intriguingly, (R)-LW-Srci-8 preferentially binds to inactive c-Src with unphosphorylated Y419 both in vitro and in cells, subsequently disrupting the autophosphorylation. Collectively, our study demonstrated the feasibility of developing selective kinase inhibitors by cotargeting a nucleophilic residue and a posttranslational modification site and providing a chemical probe for c-Src functional studies.
Collapse
Affiliation(s)
- Huimin Zhang
- Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528437, China
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
| | - Dounan Xu
- Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528437, China
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
- Department of Chemistry, College of Sciences, Shanghai University, Shanghai 200444, China
| | - Hongchan Huang
- Center for Chemical Biology and Drug Discovery, State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China
- University of Chinese Academy of Sciences (UCAS), 19 Yuquan Road, Beijing 100049, China
| | - Hao Jiang
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
| | - Linghao Hu
- Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528437, China
| | - Liping Liu
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
- University of Chinese Academy of Sciences (UCAS), 19 Yuquan Road, Beijing 100049, China
| | - Ge Sun
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
- University of Chinese Academy of Sciences (UCAS), 19 Yuquan Road, Beijing 100049, China
| | - Jing Gao
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
- University of Chinese Academy of Sciences (UCAS), 19 Yuquan Road, Beijing 100049, China
| | - Yuanqing Li
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
- University of Chinese Academy of Sciences (UCAS), 19 Yuquan Road, Beijing 100049, China
- School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China
| | - Cuicui Xia
- Division of Life Science and Medicine, University of Science and Technology of China, Hefei 230026, China
| | - Shijie Chen
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
- University of Chinese Academy of Sciences (UCAS), 19 Yuquan Road, Beijing 100049, China
| | - Hu Zhou
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
- University of Chinese Academy of Sciences (UCAS), 19 Yuquan Road, Beijing 100049, China
| | - Xiangqian Kong
- Center for Chemical Biology and Drug Discovery, State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China
- University of Chinese Academy of Sciences (UCAS), 19 Yuquan Road, Beijing 100049, China
| | - Mingliang Wang
- Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528437, China
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
| | - Cheng Luo
- Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528437, China
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
- University of Chinese Academy of Sciences (UCAS), 19 Yuquan Road, Beijing 100049, China
- School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China
| |
Collapse
|
19
|
Steffin D, Ghatwai N, Montalbano A, Rathi P, Courtney AN, Arnett AB, Fleurence J, Sweidan R, Wang T, Zhang H, Masand P, Maris JM, Martinez D, Pogoriler J, Varadarajan N, Thakkar SG, Lyon D, Lapteva N, Mei Z, Patel K, Lopez-Terrada D, Ramos C, Lulla P, Armaghany T, Grilley BJ, Dotti G, Metelitsa LS, Heslop HE, Brenner MK, Sumazin P, Heczey A. Interleukin-15-armored GPC3-CAR T cells for patients with solid cancers. Res Sq 2024:rs.3.rs-4103623. [PMID: 38645165 PMCID: PMC11030543 DOI: 10.21203/rs.3.rs-4103623/v1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/23/2024]
Abstract
Interleukin-15 (IL15) promotes the survival of T lymphocytes and enhances the antitumor properties of CAR T cells in preclinical models of solid neoplasms in which CAR T cells have limited efficacy1-4. Glypican-3 (GPC3) is expressed in a group of solid cancers5-10, and here we report the first evaluation in humans of the effects of IL15 co-expression on GPC3-CAR T cells. Cohort 1 patients (NCT02905188/NCT02932956) received GPC3-CAR T cells, which were safe but produced no objective antitumor responses and reached peak expansion at two weeks. Cohort 2 patients (NCT05103631/NCT04377932) received GPC3-CAR T cells that co-expressed IL15 (15.CAR), which mediated significantly increased cell expansion and induced a disease control rate of 66% and antitumor response rate of 33%. Infusion of 15.CAR T cells was associated with increased incidence of cytokine release syndrome, which was rapidly ameliorated by activation of the inducible caspase 9 safety switch. Compared to non-responders, tumor-infiltrating 15.CAR T cells from responders showed repression of SWI/SNF epigenetic regulators and upregulation of FOS and JUN family members as well as genes related to type I interferon signaling. Collectively, these results demonstrate that IL15 increases the expansion, intratumoral survival, and antitumor activity of GPC3-CAR T cells in patients.
Collapse
Affiliation(s)
- David Steffin
- Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas
- Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, Texas
- Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas
- Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas
| | - Nisha Ghatwai
- Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas
- Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, Texas
| | - Antonino Montalbano
- Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas
- Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, Texas
| | - Purva Rathi
- Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas
- Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, Texas
| | - Amy N Courtney
- Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas
- Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, Texas
- Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas
| | - Azlann B Arnett
- Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, Texas
- Department of Immunology and Microbiology, Baylor College of Medicine, Texas
| | - Julien Fleurence
- Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas
- Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas
| | - Ramy Sweidan
- Department of Immunology and Microbiology, Baylor College of Medicine, Texas
| | - Thao Wang
- Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas
| | - Huimin Zhang
- Department of Immunology and Microbiology, Baylor College of Medicine, Texas
| | - Prakash Masand
- Department of Radiology, Baylor College of Medicine, Houston, Texas
| | - John M Maris
- Department of Pediatrics, Children’s Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania
| | - Daniel Martinez
- Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania
| | - Jennifer Pogoriler
- Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania
| | - Navin Varadarajan
- William A. Brookshire Department of Chemical and Biomolecular Engineering, University of Houston, Houston, Texas
| | - Sachin G Thakkar
- Department of Immunology and Microbiology, Baylor College of Medicine, Texas
| | - Deborah Lyon
- Department of Immunology and Microbiology, Baylor College of Medicine, Texas
| | - Natasha Lapteva
- Department of Immunology and Microbiology, Baylor College of Medicine, Texas
- Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas
- Department of Pathology, Baylor College of Medicine, Houston, Texas
| | - Zhuyong Mei
- Department of Immunology and Microbiology, Baylor College of Medicine, Texas
| | - Kalyani Patel
- Department of Pathology, Baylor College of Medicine, Houston, Texas
| | | | - Carlos Ramos
- Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas
- Department of Immunology and Microbiology, Baylor College of Medicine, Texas
| | - Premal Lulla
- Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas
- Department of Immunology and Microbiology, Baylor College of Medicine, Texas
| | - Tannaz Armaghany
- Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas
| | - Bambi J Grilley
- Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas
- Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, Texas
- Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas
- Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas
| | - Gianpietro Dotti
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina
| | - Leonid S Metelitsa
- Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas
- Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, Texas
- Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas
- Department of Immunology and Microbiology, Baylor College of Medicine, Texas
| | - Helen E Heslop
- Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas
- Department of Immunology and Microbiology, Baylor College of Medicine, Texas
| | - Malcolm K Brenner
- Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas
- Department of Immunology and Microbiology, Baylor College of Medicine, Texas
| | - Pavel Sumazin
- Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas
- Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas
| | - Andras Heczey
- Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas
- Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, Texas
- Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas
- Texas Children’s Hospital Liver Tumor Program, Houston, Texas
| |
Collapse
|
20
|
Maimaitiyiming R, Zhang H, Wang J, Wang L, Zhao L, Liu B, Chen K, Aihaiti A. A Novel Strategy for Mixed Jam Evaluation: Apparent Indicator, Sensory, Metabolomic, and GC-IMS Analysis. Foods 2024; 13:1104. [PMID: 38611408 PMCID: PMC11011859 DOI: 10.3390/foods13071104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/29/2024] [Revised: 03/29/2024] [Accepted: 04/01/2024] [Indexed: 04/14/2024] Open
Abstract
Jam is a popular traditional and modern food product for daily consumption. However, the benefits of mixed jams over single-fruit jams have not been thoroughly explored, with analyses limited to superficial indices. In this study, Xinjiang special Morus nigra L. and Prunus domestica L. were used as raw materials to prepare single-fruit and mixed jams, and their differences in antioxidants, organoleptic qualities, pH, texture, and color were analyzed. The dynamics of metabolites before and after thermal processing were assessed using untargeted metabolomics. The results indicate that the main metabolites were flavonoids, terpenoids, amino acids, phenolic acids, and carbohydrates. Flavonoid metabolites changed significantly after thermal processing, with 40 up-regulated and 13 down-regulated. During storage, polyphenols were the prominent differential metabolites, with fifty-four down-regulated and one up-regulated. Volatile aroma components were analyzed using gas chromatography-ion mobility spectrometry (GC-IMS); the aroma components E-2-hexenal, E-2-pentenal, 3-methylbutanal, 1-penten-3-ol, tetrahydro-linalool, 1-penten-3-one, hexyl propionate, isoamyl acetate, α-pinene, and propionic acid in mixed jam were significantly higher than in single-fruit jam. In this study, untargeted metabolomics and GC-IMS were used to provide a more comprehensive and in-depth evaluation system for jam analysis.
Collapse
Affiliation(s)
- Ruxianguli Maimaitiyiming
- School of Life Science and Technology, Xinjiang University, Urumqi 830046, China; (R.M.); (H.Z.); (J.W.); (L.W.); (L.Z.), (B.L.)
| | - Huimin Zhang
- School of Life Science and Technology, Xinjiang University, Urumqi 830046, China; (R.M.); (H.Z.); (J.W.); (L.W.); (L.Z.), (B.L.)
| | - Jiayi Wang
- School of Life Science and Technology, Xinjiang University, Urumqi 830046, China; (R.M.); (H.Z.); (J.W.); (L.W.); (L.Z.), (B.L.)
| | - Liang Wang
- School of Life Science and Technology, Xinjiang University, Urumqi 830046, China; (R.M.); (H.Z.); (J.W.); (L.W.); (L.Z.), (B.L.)
| | - Lei Zhao
- School of Life Science and Technology, Xinjiang University, Urumqi 830046, China; (R.M.); (H.Z.); (J.W.); (L.W.); (L.Z.), (B.L.)
| | - Bingze Liu
- School of Life Science and Technology, Xinjiang University, Urumqi 830046, China; (R.M.); (H.Z.); (J.W.); (L.W.); (L.Z.), (B.L.)
| | - Keping Chen
- Xinjiang Huize Food Limited Liability Company, Urumqi 830046, China;
| | - Aihemaitijiang Aihaiti
- School of Life Science and Technology, Xinjiang University, Urumqi 830046, China; (R.M.); (H.Z.); (J.W.); (L.W.); (L.Z.), (B.L.)
| |
Collapse
|
21
|
Zhao J, Zhu X, Zhang W, Qiu J, Zhai F, Zhang H, Cao G, Gao S, Ding F, Xiang Y. Expanded graphite incorporated with Li 4Ti 5O 12 nanoparticles as a high-rate lithium-ion battery anode. RSC Adv 2024; 14:11276-11283. [PMID: 38595709 PMCID: PMC11002838 DOI: 10.1039/d4ra00832d] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2024] [Accepted: 03/26/2024] [Indexed: 04/11/2024] Open
Abstract
Due to their small interlayer spacing and a low lithiation potential close to Li+ deposition, current graphite anodes suffer from weak kinetics, and lithium deposition in a fast-charging process, hindering their practical application in high-power lithium-ion batteries (LIBs). In this work, expanded graphite incorporated with Li4Ti5O12 nanoparticles (EG/LTO) was synthesized via moderate oxidization of artificial graphite following a solution coating process. The EG/LTO has sufficient porosity for fast Li+ diffusion and a dense Li4Ti5O12 layer for decreased interface reaction resistance, resulting in excellent fast-charging properties. EG/LTO presented a high reversible capacity of 272.8 mA h g-1 at 3.74 A g-1 (10C), much higher than that of the original commercial graphite (50.1 mA h g-1 at 10C) and even superior to that of hard carbon. In addition, EG/LTO exhibited capacity retention rate of 98.4% after 500 cycles at 10C, demonstrating high structural stability during a long cycling process. This study provides a protocol for a solution chemistry method to prepare fast-charging graphite anode materials with high stability for high-power LIBs.
Collapse
Affiliation(s)
- Junkang Zhao
- Hebei University of Technology Tianjin 100131 China
- Chemical Defense Institute, Academy of Military Sciences Beijing 100191 China
| | - Xiayu Zhu
- Chemical Defense Institute, Academy of Military Sciences Beijing 100191 China
- Beijing Key Laboratory of Advanced Chemical Energy Storage Technology and Materials Beijing 100191 China
| | - Wenfeng Zhang
- Chemical Defense Institute, Academy of Military Sciences Beijing 100191 China
- Beijing Key Laboratory of Advanced Chemical Energy Storage Technology and Materials Beijing 100191 China
| | - Jingyi Qiu
- Chemical Defense Institute, Academy of Military Sciences Beijing 100191 China
- Beijing Key Laboratory of Advanced Chemical Energy Storage Technology and Materials Beijing 100191 China
| | - Feiyue Zhai
- Chemical Defense Institute, Academy of Military Sciences Beijing 100191 China
- Beihang University Beijing 100191 China
| | - Huimin Zhang
- Chemical Defense Institute, Academy of Military Sciences Beijing 100191 China
- Beijing Key Laboratory of Advanced Chemical Energy Storage Technology and Materials Beijing 100191 China
| | - Gaoping Cao
- Chemical Defense Institute, Academy of Military Sciences Beijing 100191 China
- Beijing Key Laboratory of Advanced Chemical Energy Storage Technology and Materials Beijing 100191 China
| | - Shengji Gao
- Hebei University of Technology Tianjin 100131 China
- Chemical Defense Institute, Academy of Military Sciences Beijing 100191 China
| | - Fei Ding
- Hebei University of Technology Tianjin 100131 China
| | - Yu Xiang
- Chemical Defense Institute, Academy of Military Sciences Beijing 100191 China
- Beijing Key Laboratory of Advanced Chemical Energy Storage Technology and Materials Beijing 100191 China
| |
Collapse
|
22
|
Zhang H, Li K, Guo X, Zhang L, Cao D, Cheng D. Rational Regulation of the Defect Density in Platinum Nanocrystals for Highly Efficient Hydrogen Evolution Reaction. Small 2024; 20:e2306694. [PMID: 38044277 DOI: 10.1002/smll.202306694] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/04/2023] [Revised: 11/02/2023] [Indexed: 12/05/2023]
Abstract
Constructing structural defects is a promising way to enhance the catalytic activity toward the hydrogen evolution reaction (HER). However, the relationship between defect density and HER activity has rarely been discussed. In this study, a series of Pt/WOx nanocrystals are fabricated with controlled morphologies and structural defect densities using a facile one-step wet chemical method. Remarkably, compared with polygonal and star structures, the dendritic Pt/WOx (d-Pt/WOx) exhibited a richer structural defect density, including stepped surfaces and atomic defects. Notably, the d-Pt/WOx catalyst required 4 and 16 mV to reach 10 mA cm-2, and its turnover frequency (TOF) values are 11.6 and 22.8 times higher than that of Pt/C under acidic and alkaline conditions, respectively. In addition, d-Pt/WOx//IrO2 displayed a mass activity of 5158 mA mgPt -1 at 2.0 V in proton exchange membrane water electrolyzers (PEMWEs), which is significantly higher than that of the commercial Pt/C//IrO2 system. Further mechanistic studies suggested that the d-Pt/WOx exhibited reduced number of antibonding bands and the lowest dz2-band center, contributing to hydrogen adsorption and release in acidic solution. The highest dz2-band center of d-Pt/WOx facilitated the adsorption of hydrogen from water molecules and water dissociation in alkaline medium. This work emphasizes the key role of the defect density in improving the HER activity of electrocatalysts.
Collapse
Affiliation(s)
- Huimin Zhang
- State Key Laboratory of Organic-Inorganic Composites and Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, Beijing, 100029, People's Republic of China
| | - Kai Li
- State Key Laboratory of Organic-Inorganic Composites and Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, Beijing, 100029, People's Republic of China
| | - Xiaoyan Guo
- State Key Laboratory of Organic-Inorganic Composites and Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, Beijing, 100029, People's Republic of China
| | - Lipeng Zhang
- State Key Laboratory of Organic-Inorganic Composites and Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, Beijing, 100029, People's Republic of China
| | - Dong Cao
- State Key Laboratory of Organic-Inorganic Composites and Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, Beijing, 100029, People's Republic of China
| | - Daojian Cheng
- State Key Laboratory of Organic-Inorganic Composites and Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, Beijing, 100029, People's Republic of China
- College of Chemistry and Chemical Engineering, Tarim University, Alar, XinJiang, 843300, People's Republic of China
| |
Collapse
|
23
|
Zhang H, Ren M, Wang Y, Jin Z, Zhang S, Liu J, Fu J, Qin H. In Vivo Microwave-Induced Thermoacoustic Endoscopy for Colorectal Tumor Detection in Deep Tissue. IEEE Trans Med Imaging 2024; 43:1619-1627. [PMID: 38113149 DOI: 10.1109/tmi.2023.3345008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/21/2023]
Abstract
Optical endoscopy, as one of the common clinical diagnostic modalities, provides irreplaceable advantages in the diagnosis and treatment of internal organs. However, the approach is limited to the characterization of superficial tissues due to the strong optical scattering properties of tissue. In this work, a microwave-induced thermoacoustic (TA) endoscope (MTAE) was developed and evaluated. The MTAE system integrated a homemade monopole sleeve antenna (diameter = 7 mm) for providing homogenized pulsed microwave irradiation to induce a TA signal in the colorectal cavity and a side-viewing focus ultrasonic transducer (diameter = 3 mm) for detecting the TA signal in the ultrasonic spectrum to construct the image. Our MTAE, system combined microwave excitation and acoustic detection; produced images with dielectric contrast and high spatial resolution at several centimeters deep in soft tissues, overcome the current limitations of the imaging depth of optical endoscopy and mechanical wave-based imaging contrast of ultrasound endoscopy, and had the ability to extract complete features for deep location tumors that could be infiltrating and invading adjacent structures. The practical feasibility of the MTAE system was evaluated i n vivo with rabbits having colorectal tumors. The results demonstrated that colorectal tumor progression could be visualized from the changes in electromagnetic parameters of the tissue via MTAE, showing its potential clinical application.
Collapse
|
24
|
Jiang Y, Zhu D, Huang X, Li Y, Chen Y, Jiang Y, Wang W, Guo L, Chen Y, Liao Y, Liu Y, Zhang H, Le GH, McIntyre RS, Fan B, Lu C. Associations between somatic symptoms and remission of major depressive disorder: A longitudinal study in China. J Psychiatr Res 2024; 172:382-390. [PMID: 38452636 DOI: 10.1016/j.jpsychires.2024.02.056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/07/2023] [Revised: 02/17/2024] [Accepted: 02/24/2024] [Indexed: 03/09/2024]
Abstract
Previous studies have documented negative associations between somatic symptoms and remission of major depressive disorder (MDD). However, the correlations of specific somatic symptoms with remission remain uncertain. We aimed to explore the associations between specific somatic symptoms and remission focusing on sex differences among patients with MDD. We used data from patients with MDD in the Depression Cohort in China. At baseline, total somatic symptoms were evaluated using the 28-item Somatic Symptoms Inventory and were categorized into pain, autonomic, energy, and central nervous system (CNS) symptoms. To measure remission of MDD, depressive symptoms were evaluated using the Patient Health Questionnaire-9 after 3 months of treatment. We ultimately included 634 patients. Compared with quartile 1 of total somatic symptom scores, the full-adjusted ORs (95% CIs) for remission from quartile 2 to quartile 4 were 0.52 (0.30, 0.90), 0.44 (0.23, 0.83), and 0.36 (0.17, 0.75), respectively (P-value for trend = 0.005). The restricted cubic spline showed no non-linear associations between total somatic symptoms with remission (P-value for non-linear = 0.238). Pain, autonomic, and CNS symptoms showed similar results. Sex-stratified analysis showed that total somatic symptoms, pain symptoms, and autonomic symptoms were negatively correlated with remission in females, whereas CNS symptoms were negatively associated with remission in males. Our findings indicate that specific somatic symptoms exert differential effects on remission of MDD. Therapeutic interventions that target pain, autonomic, and CNS symptoms may increase the probability of remission. Furthermore, interventions for somatic symptoms should be tailored by sex, and females deserve more attention.
Collapse
Affiliation(s)
- Yingchen Jiang
- Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, 510080, China; Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Sun Yat-sen University, Guangzhou, 510080, China
| | - Dongjian Zhu
- Department of Psychiatry, Shenzhen Nanshan Center for Chronic Disease Control, Shenzhen, China
| | - Xinyu Huang
- Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, 510080, China; Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Sun Yat-sen University, Guangzhou, 510080, China
| | - Yanzhi Li
- Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, 510080, China; Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Sun Yat-sen University, Guangzhou, 510080, China
| | - Ya Chen
- Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, 510080, China; Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Sun Yat-sen University, Guangzhou, 510080, China
| | - Yunbin Jiang
- Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, 510080, China; Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Sun Yat-sen University, Guangzhou, 510080, China
| | - Wanxin Wang
- Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, 510080, China; Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Sun Yat-sen University, Guangzhou, 510080, China
| | - Lan Guo
- Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, 510080, China; Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Sun Yat-sen University, Guangzhou, 510080, China
| | - Yan Chen
- Department of Psychiatry, Shenzhen Nanshan Center for Chronic Disease Control, Shenzhen, China
| | - Yuhua Liao
- Department of Psychiatry, Shenzhen Nanshan Center for Chronic Disease Control, Shenzhen, China
| | - Yifeng Liu
- Department of Psychiatry, Shenzhen Nanshan Center for Chronic Disease Control, Shenzhen, China
| | - Huimin Zhang
- Department of Psychiatry, Shenzhen Nanshan Center for Chronic Disease Control, Shenzhen, China
| | - Gia Han Le
- Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada
| | - Roger S McIntyre
- Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada
| | - Beifang Fan
- Department of Psychiatry, Shenzhen Nanshan Center for Chronic Disease Control, Shenzhen, China.
| | - Ciyong Lu
- Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, 510080, China; Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Sun Yat-sen University, Guangzhou, 510080, China.
| |
Collapse
|
25
|
Yin L, Hu X, Pei G, Tang M, Zhou Y, Zhang H, Huang M, Li S, Zhang J, Citu C, Zhao Z, Debeb BG, Feng X, Chen J. Genome-wide CRISPR screen reveals the synthetic lethality between BCL2L1 inhibition and radiotherapy. Life Sci Alliance 2024; 7:e202302353. [PMID: 38316463 PMCID: PMC10844523 DOI: 10.26508/lsa.202302353] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2023] [Revised: 01/21/2024] [Accepted: 01/22/2024] [Indexed: 02/07/2024] Open
Abstract
Radiation therapy (RT) is one of the most commonly used anticancer therapies. However, the landscape of cellular response to irradiation, especially to a single high-dose irradiation, remains largely unknown. In this study, we performed a whole-genome CRISPR loss-of-function screen and revealed temporal inherent and acquired responses to RT. Specifically, we found that loss of the IL1R1 pathway led to cellular resistance to RT. This is in part because of the involvement of radiation-induced IL1R1-dependent transcriptional regulation, which relies on the NF-κB pathway. Moreover, the mitochondrial anti-apoptotic pathway, particularly the BCL2L1 gene, is crucially important for cell survival after radiation. BCL2L1 inhibition combined with RT dramatically impeded tumor growth in several breast cancer cell lines and syngeneic models. Taken together, our results suggest that the combination of an apoptosis inhibitor such as a BCL2L1 inhibitor with RT may represent a promising anticancer strategy for solid cancers including breast cancer.
Collapse
Affiliation(s)
- Ling Yin
- https://ror.org/04twxam07 Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - Xiaoding Hu
- https://ror.org/04twxam07 Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- https://ror.org/04twxam07 Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - Guangsheng Pei
- Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA
- Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA
| | - Mengfan Tang
- https://ror.org/04twxam07 Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - You Zhou
- https://ror.org/04twxam07 Department of Pediatrics Research, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - Huimin Zhang
- https://ror.org/04twxam07 Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - Min Huang
- https://ror.org/04twxam07 Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - Siting Li
- https://ror.org/04twxam07 Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - Jie Zhang
- https://ror.org/04twxam07 Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - Citu Citu
- Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA
- Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA
| | - Zhongming Zhao
- Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA
- Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA
| | - Bisrat G Debeb
- https://ror.org/04twxam07 Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- https://ror.org/04twxam07 Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - Xu Feng
- https://ror.org/04twxam07 Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Pancreas Center, First Affiliated Hospital of Nanjing Medical University, Nanjing, China
- Pancreas Institute, Nanjing Medical University, Nanjing, China
| | - Junjie Chen
- https://ror.org/04twxam07 Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| |
Collapse
|
26
|
Heczey A, Xu X, Courtney AN, Tian G, Barragan GA, Guo L, Amador CM, Ghatwai N, Rathi P, Wood MS, Li Y, Zhang C, Demberg T, Di Pierro EJ, Sher AC, Zhang H, Mehta B, Thakkar SG, Grilley B, Wang T, Weiss BD, Montalbano A, Subramaniam M, Xu C, Sachar C, Wells DK, Dotti G, Metelitsa LS. Author Correction: Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results. Nat Med 2024; 30:1210. [PMID: 38195754 DOI: 10.1038/s41591-024-02799-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2024]
Affiliation(s)
- Andras Heczey
- Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA.
- Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA.
| | - Xin Xu
- Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA
| | - Amy N Courtney
- Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA
| | - Gengwen Tian
- Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA
| | - Gabriel A Barragan
- Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA
| | - Linjie Guo
- Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA
| | - Claudia Martinez Amador
- Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA
| | - Nisha Ghatwai
- Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA
| | - Purva Rathi
- Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA
| | - Michael S Wood
- Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA
| | - Yanchuan Li
- Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA
| | - Chunchao Zhang
- Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA
| | - Thorsten Demberg
- Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA
| | - Erica J Di Pierro
- Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA
| | - Andrew C Sher
- Department of Radiology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA
| | - Huimin Zhang
- Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA
| | - Birju Mehta
- Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA
| | - Sachin G Thakkar
- Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA
| | - Bambi Grilley
- Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA
| | - Tao Wang
- Biostatistics and Data Management Resource, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA
| | - Brian D Weiss
- Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, OH, USA
| | | | | | | | | | | | - Gianpietro Dotti
- Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - Leonid S Metelitsa
- Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA.
- Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA.
| |
Collapse
|
27
|
Chang Y, Xie X, Liu Y, Liu M, Zhang H. Exploring clinical applications and long-term effectiveness of benzodiazepines: An integrated perspective on mechanisms, imaging, and personalized medicine. Biomed Pharmacother 2024; 173:116329. [PMID: 38401518 DOI: 10.1016/j.biopha.2024.116329] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2023] [Revised: 02/13/2024] [Accepted: 02/21/2024] [Indexed: 02/26/2024] Open
Abstract
Benzodiazepines have been long-established treatments for various conditions, including anxiety disorders and insomnia. Recent FDA warnings emphasize the risks of misuse and dependence associated with benzodiazepines. This article highlights their benefits and potential drawbacks from various perspectives. It achieves this by explaining how benzodiazepines work in terms of neuroendocrinology, immunomodulation, sleep, anxiety, cognition, and addiction, ultimately improving their clinical effectiveness. Benzodiazepines play a regulatory role in the HPA axis and impact various systems, including neuropeptide Y and cholecystokinin. Benzodiazepines can facilitate sleep-dependent memory consolidation by promoting spindle wave activity, but they can also lead to memory deficits in older individuals due to reduced slow-wave sleep. The cognitive effects of chronic benzodiazepines use remain uncertain; however, no adverse findings have been reported in clinical imaging studies. This article aims to comprehensively review the evidence on benzodiazepines therapy, emphasizing the need for more clinical studies, especially regarding long-term benzodiazepines use.
Collapse
Affiliation(s)
- Yiheng Chang
- Department of Neurology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China
| | - Xueting Xie
- Department of Neurology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China
| | - Yudan Liu
- Department of Neurology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China
| | - Meichen Liu
- Department of Neurology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
| | - Huimin Zhang
- Department of Neurology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
| |
Collapse
|
28
|
Cao Z, Aharonian F, Axikegu, Bai YX, Bao YW, Bastieri D, Bi XJ, Bi YJ, Bian W, Bukevich AV, Cao Q, Cao WY, Cao Z, Chang J, Chang JF, Chen AM, Chen ES, Chen HX, Chen L, Chen L, Chen L, Chen MJ, Chen ML, Chen QH, Chen S, Chen SH, Chen SZ, Chen TL, Chen Y, Cheng N, Cheng YD, Cui MY, Cui SW, Cui XH, Cui YD, Dai BZ, Dai HL, Dai ZG, Danzengluobu, Dong XQ, Duan KK, Fan JH, Fan YZ, Fang J, Fang JH, Fang K, Feng CF, Feng H, Feng L, Feng SH, Feng XT, Feng Y, Feng YL, Gabici S, Gao B, Gao CD, Gao Q, Gao W, Gao WK, Ge MM, Geng LS, Giacinti G, Gong GH, Gou QB, Gu MH, Guo FL, Guo XL, Guo YQ, Guo YY, Han YA, Hasan M, He HH, He HN, He JY, He Y, Hor YK, Hou BW, Hou C, Hou X, Hu HB, Hu Q, Hu SC, Huang DH, Huang TQ, Huang WJ, Huang XT, Huang XY, Huang Y, Ji XL, Jia HY, Jia K, Jiang K, Jiang XW, Jiang ZJ, Jin M, Kang MM, Karpikov I, Kuleshov D, Kurinov K, Li BB, Li CM, Li C, Li C, Li D, Li F, Li HB, Li HC, Li J, Li J, Li K, Li SD, Li WL, Li WL, Li XR, Li X, Li YZ, Li Z, Li Z, Liang EW, Liang YF, Lin SJ, Liu B, Liu C, Liu D, Liu DB, Liu H, Liu HD, Liu J, Liu JL, Liu MY, Liu RY, Liu SM, Liu W, Liu Y, Liu YN, Luo Q, Luo Y, Lv HK, Ma BQ, Ma LL, Ma XH, Mao JR, Min Z, Mitthumsiri W, Mu HJ, Nan YC, Neronov A, Ou LJ, Pattarakijwanich P, Pei ZY, Qi JC, Qi MY, Qiao BQ, Qin JJ, Raza A, Ruffolo D, Sáiz A, Saeed M, Semikoz D, Shao L, Shchegolev O, Sheng XD, Shu FW, Song HC, Stenkin YV, Stepanov V, Su Y, Sun DX, Sun QN, Sun XN, Sun ZB, Takata J, Tam PHT, Tang QW, Tang R, Tang ZB, Tian WW, Wang C, Wang CB, Wang GW, Wang HG, Wang HH, Wang JC, Wang K, Wang K, Wang LP, Wang LY, Wang PH, Wang R, Wang W, Wang XG, Wang XY, Wang Y, Wang YD, Wang YJ, Wang ZH, Wang ZX, Wang Z, Wang Z, Wei DM, Wei JJ, Wei YJ, Wen T, Wu CY, Wu HR, Wu QW, Wu S, Wu XF, Wu YS, Xi SQ, Xia J, Xiang GM, Xiao DX, Xiao G, Xin YL, Xing Y, Xiong DR, Xiong Z, Xu DL, Xu RF, Xu RX, Xu WL, Xue L, Yan DH, Yan JZ, Yan T, Yang CW, Yang CY, Yang F, Yang FF, Yang LL, Yang MJ, Yang RZ, Yang WX, Yao YH, Yao ZG, Yin LQ, Yin N, You XH, You ZY, Yu YH, Yuan Q, Yue H, Zeng HD, Zeng TX, Zeng W, Zha M, Zhang BB, Zhang F, Zhang H, Zhang HM, Zhang HY, Zhang JL, Zhang L, Zhang PF, Zhang PP, Zhang R, Zhang SB, Zhang SR, Zhang SS, Zhang X, Zhang XP, Zhang YF, Zhang Y, Zhang Y, Zhao B, Zhao J, Zhao L, Zhao LZ, Zhao SP, Zhao XH, Zheng F, Zhong WJ, Zhou B, Zhou H, Zhou JN, Zhou M, Zhou P, Zhou R, Zhou XX, Zhou XX, Zhu BY, Zhu CG, Zhu FR, Zhu H, Zhu KJ, Zou YC, Zuo X. Measurements of All-Particle Energy Spectrum and Mean Logarithmic Mass of Cosmic Rays from 0.3 to 30 PeV with LHAASO-KM2A. Phys Rev Lett 2024; 132:131002. [PMID: 38613275 DOI: 10.1103/physrevlett.132.131002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/13/2023] [Revised: 01/23/2024] [Accepted: 02/12/2024] [Indexed: 04/14/2024]
Abstract
We present the measurements of all-particle energy spectrum and mean logarithmic mass of cosmic rays in the energy range of 0.3-30 PeV using data collected from LHAASO-KM2A between September 2021 and December 2022, which is based on a nearly composition-independent energy reconstruction method, achieving unprecedented accuracy. Our analysis reveals the position of the knee at 3.67±0.05±0.15 PeV. Below the knee, the spectral index is found to be -2.7413±0.0004±0.0050, while above the knee, it is -3.128±0.005±0.027, with the sharpness of the transition measured with a statistical error of 2%. The mean logarithmic mass of cosmic rays is almost heavier than helium in the whole measured energy range. It decreases from 1.7 at 0.3 PeV to 1.3 at 3 PeV, representing a 24% decline following a power law with an index of -0.1200±0.0003±0.0341. This is equivalent to an increase in abundance of light components. Above the knee, the mean logarithmic mass exhibits a power law trend towards heavier components, which is reversal to the behavior observed in the all-particle energy spectrum. Additionally, the knee position and the change in power-law index are approximately the same. These findings suggest that the knee observed in the all-particle spectrum corresponds to the knee of the light component, rather than the medium-heavy components.
Collapse
Affiliation(s)
- Zhen Cao
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - F Aharonian
- Dublin Institute for Advanced Studies, 31 Fitzwilliam Place, 2 Dublin, Ireland
- Max-Planck-Institut for Nuclear Physics, P.O. Box 103980, 69029 Heidelberg, Germany
| | - Axikegu
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Y X Bai
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y W Bao
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - D Bastieri
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - X J Bi
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y J Bi
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - W Bian
- Tsung-Dao Lee Institute and School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - A V Bukevich
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
| | - Q Cao
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - W Y Cao
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Zhe Cao
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - J Chang
- Key Laboratory of Dark Matter and Space Astronomy and Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J F Chang
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - A M Chen
- Tsung-Dao Lee Institute and School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - E S Chen
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - H X Chen
- Research Center for Astronomical Computing, Zhejiang Laboratory, 311121 Hangzhou, Zhejiang, China
| | - Liang Chen
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - Lin Chen
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Long Chen
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - M J Chen
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - M L Chen
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - Q H Chen
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - S Chen
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - S H Chen
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - S Z Chen
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - T L Chen
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - Y Chen
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - N Cheng
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y D Cheng
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - M Y Cui
- Key Laboratory of Dark Matter and Space Astronomy and Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - S W Cui
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - X H Cui
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - Y D Cui
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai and 510275 Guangzhou, Guangdong, China
| | - B Z Dai
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - H L Dai
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - Z G Dai
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Danzengluobu
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - X Q Dong
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - K K Duan
- Key Laboratory of Dark Matter and Space Astronomy and Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J H Fan
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - Y Z Fan
- Key Laboratory of Dark Matter and Space Astronomy and Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J Fang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - J H Fang
- Research Center for Astronomical Computing, Zhejiang Laboratory, 311121 Hangzhou, Zhejiang, China
| | - K Fang
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - C F Feng
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - H Feng
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
| | - L Feng
- Key Laboratory of Dark Matter and Space Astronomy and Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - S H Feng
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - X T Feng
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - Y Feng
- Research Center for Astronomical Computing, Zhejiang Laboratory, 311121 Hangzhou, Zhejiang, China
| | - Y L Feng
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - S Gabici
- APC, Université Paris Cité, CNRS/IN2P3, CEA/IRFU, Observatoire de Paris, 119 75205 Paris, France
| | - B Gao
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - C D Gao
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - Q Gao
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - W Gao
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - W K Gao
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - M M Ge
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - L S Geng
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - G Giacinti
- Tsung-Dao Lee Institute and School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - G H Gong
- Department of Engineering Physics, Tsinghua University, 100084 Beijing, China
| | - Q B Gou
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - M H Gu
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - F L Guo
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - X L Guo
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Y Q Guo
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y Y Guo
- Key Laboratory of Dark Matter and Space Astronomy and Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Y A Han
- School of Physics and Microelectronics, Zhengzhou University, 450001 Zhengzhou, Henan, China
| | - M Hasan
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - H H He
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - H N He
- Key Laboratory of Dark Matter and Space Astronomy and Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J Y He
- Key Laboratory of Dark Matter and Space Astronomy and Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Y He
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Y K Hor
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai and 510275 Guangzhou, Guangdong, China
| | - B W Hou
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - C Hou
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - X Hou
- Yunnan Observatories, Chinese Academy of Sciences, 650216 Kunming, Yunnan, China
| | - H B Hu
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Q Hu
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy and Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - S C Hu
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- China Center of Advanced Science and Technology, Beijing 100190, China
| | - D H Huang
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - T Q Huang
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - W J Huang
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai and 510275 Guangzhou, Guangdong, China
| | - X T Huang
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - X Y Huang
- Key Laboratory of Dark Matter and Space Astronomy and Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Y Huang
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - X L Ji
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - H Y Jia
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - K Jia
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - K Jiang
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - X W Jiang
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Z J Jiang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - M Jin
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - M M Kang
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - I Karpikov
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
| | - D Kuleshov
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
| | - K Kurinov
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
| | - B B Li
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - C M Li
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - Cheng Li
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - Cong Li
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - D Li
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - F Li
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - H B Li
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - H C Li
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Jian Li
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Jie Li
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - K Li
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - S D Li
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - W L Li
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - W L Li
- Tsung-Dao Lee Institute and School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - X R Li
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Xin Li
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - Y Z Li
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Zhe Li
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Zhuo Li
- School of Physics, Peking University, 100871 Beijing, China
| | - E W Liang
- Guangxi Key Laboratory for Relativistic Astrophysics, School of Physical Science and Technology, Guangxi University, 530004 Nanning, Guangxi, China
| | - Y F Liang
- Guangxi Key Laboratory for Relativistic Astrophysics, School of Physical Science and Technology, Guangxi University, 530004 Nanning, Guangxi, China
| | - S J Lin
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai and 510275 Guangzhou, Guangdong, China
| | - B Liu
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - C Liu
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - D Liu
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - D B Liu
- Tsung-Dao Lee Institute and School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - H Liu
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - H D Liu
- School of Physics and Microelectronics, Zhengzhou University, 450001 Zhengzhou, Henan, China
| | - J Liu
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - J L Liu
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - M Y Liu
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - R Y Liu
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - S M Liu
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - W Liu
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y Liu
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - Y N Liu
- Department of Engineering Physics, Tsinghua University, 100084 Beijing, China
| | - Q Luo
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai and 510275 Guangzhou, Guangdong, China
| | - Y Luo
- Tsung-Dao Lee Institute and School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - H K Lv
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - B Q Ma
- School of Physics, Peking University, 100871 Beijing, China
| | - L L Ma
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - X H Ma
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - J R Mao
- Yunnan Observatories, Chinese Academy of Sciences, 650216 Kunming, Yunnan, China
| | - Z Min
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - W Mitthumsiri
- Department of Physics, Faculty of Science, Mahidol University, Bangkok 10400, Thailand
| | - H J Mu
- School of Physics and Microelectronics, Zhengzhou University, 450001 Zhengzhou, Henan, China
| | - Y C Nan
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - A Neronov
- APC, Université Paris Cité, CNRS/IN2P3, CEA/IRFU, Observatoire de Paris, 119 75205 Paris, France
| | - L J Ou
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - P Pattarakijwanich
- Department of Physics, Faculty of Science, Mahidol University, Bangkok 10400, Thailand
| | - Z Y Pei
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - J C Qi
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - M Y Qi
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - B Q Qiao
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - J J Qin
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - A Raza
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - D Ruffolo
- Department of Physics, Faculty of Science, Mahidol University, Bangkok 10400, Thailand
| | - A Sáiz
- Department of Physics, Faculty of Science, Mahidol University, Bangkok 10400, Thailand
| | - M Saeed
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - D Semikoz
- APC, Université Paris Cité, CNRS/IN2P3, CEA/IRFU, Observatoire de Paris, 119 75205 Paris, France
| | - L Shao
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - O Shchegolev
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
- Moscow Institute of Physics and Technology, 141700 Moscow, Russia
| | - X D Sheng
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - F W Shu
- Center for Relativistic Astrophysics and High Energy Physics, School of Physics and Materials Science and Institute of Space Science and Technology, Nanchang University, 330031 Nanchang, Jiangxi, China
| | - H C Song
- School of Physics, Peking University, 100871 Beijing, China
| | - Yu V Stenkin
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
- Moscow Institute of Physics and Technology, 141700 Moscow, Russia
| | - V Stepanov
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
| | - Y Su
- Key Laboratory of Dark Matter and Space Astronomy and Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - D X Sun
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy and Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Q N Sun
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - X N Sun
- Guangxi Key Laboratory for Relativistic Astrophysics, School of Physical Science and Technology, Guangxi University, 530004 Nanning, Guangxi, China
| | - Z B Sun
- National Space Science Center, Chinese Academy of Sciences, 100190 Beijing, China
| | - J Takata
- School of Physics, Huazhong University of Science and Technology, Wuhan 430074, Hubei, China
| | - P H T Tam
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai and 510275 Guangzhou, Guangdong, China
| | - Q W Tang
- Center for Relativistic Astrophysics and High Energy Physics, School of Physics and Materials Science and Institute of Space Science and Technology, Nanchang University, 330031 Nanchang, Jiangxi, China
| | - R Tang
- Tsung-Dao Lee Institute and School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - Z B Tang
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - W W Tian
- University of Chinese Academy of Sciences, 100049 Beijing, China
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - C Wang
- National Space Science Center, Chinese Academy of Sciences, 100190 Beijing, China
| | - C B Wang
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - G W Wang
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - H G Wang
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - H H Wang
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai and 510275 Guangzhou, Guangdong, China
| | - J C Wang
- Yunnan Observatories, Chinese Academy of Sciences, 650216 Kunming, Yunnan, China
| | - Kai Wang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - Kai Wang
- School of Physics, Huazhong University of Science and Technology, Wuhan 430074, Hubei, China
| | - L P Wang
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - L Y Wang
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - P H Wang
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - R Wang
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - W Wang
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai and 510275 Guangzhou, Guangdong, China
| | - X G Wang
- Guangxi Key Laboratory for Relativistic Astrophysics, School of Physical Science and Technology, Guangxi University, 530004 Nanning, Guangxi, China
| | - X Y Wang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - Y Wang
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Y D Wang
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y J Wang
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Z H Wang
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - Z X Wang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - Zhen Wang
- Tsung-Dao Lee Institute and School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - Zheng Wang
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - D M Wei
- Key Laboratory of Dark Matter and Space Astronomy and Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J J Wei
- Key Laboratory of Dark Matter and Space Astronomy and Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Y J Wei
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - T Wen
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - C Y Wu
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - H R Wu
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Q W Wu
- School of Physics, Huazhong University of Science and Technology, Wuhan 430074, Hubei, China
| | - S Wu
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - X F Wu
- Key Laboratory of Dark Matter and Space Astronomy and Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Y S Wu
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - S Q Xi
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - J Xia
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy and Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - G M Xiang
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - D X Xiao
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - G Xiao
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y L Xin
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Y Xing
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - D R Xiong
- Yunnan Observatories, Chinese Academy of Sciences, 650216 Kunming, Yunnan, China
| | - Z Xiong
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - D L Xu
- Tsung-Dao Lee Institute and School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - R F Xu
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - R X Xu
- School of Physics, Peking University, 100871 Beijing, China
| | - W L Xu
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - L Xue
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - D H Yan
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - J Z Yan
- Key Laboratory of Dark Matter and Space Astronomy and Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - T Yan
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - C W Yang
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - C Y Yang
- Yunnan Observatories, Chinese Academy of Sciences, 650216 Kunming, Yunnan, China
| | - F Yang
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - F F Yang
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - L L Yang
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai and 510275 Guangzhou, Guangdong, China
| | - M J Yang
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - R Z Yang
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - W X Yang
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - Y H Yao
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Z G Yao
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - L Q Yin
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - N Yin
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - X H You
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Z Y You
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y H Yu
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Q Yuan
- Key Laboratory of Dark Matter and Space Astronomy and Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - H Yue
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - H D Zeng
- Key Laboratory of Dark Matter and Space Astronomy and Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - T X Zeng
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - W Zeng
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - M Zha
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - B B Zhang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - F Zhang
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - H Zhang
- Tsung-Dao Lee Institute and School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - H M Zhang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - H Y Zhang
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - J L Zhang
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - Li Zhang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - P F Zhang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - P P Zhang
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy and Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - R Zhang
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy and Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - S B Zhang
- University of Chinese Academy of Sciences, 100049 Beijing, China
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - S R Zhang
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - S S Zhang
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - X Zhang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - X P Zhang
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y F Zhang
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Yi Zhang
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Key Laboratory of Dark Matter and Space Astronomy and Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Yong Zhang
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - B Zhao
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - J Zhao
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - L Zhao
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - L Z Zhao
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - S P Zhao
- Key Laboratory of Dark Matter and Space Astronomy and Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - X H Zhao
- Yunnan Observatories, Chinese Academy of Sciences, 650216 Kunming, Yunnan, China
| | - F Zheng
- National Space Science Center, Chinese Academy of Sciences, 100190 Beijing, China
| | - W J Zhong
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - B Zhou
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - H Zhou
- Tsung-Dao Lee Institute and School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - J N Zhou
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - M Zhou
- Center for Relativistic Astrophysics and High Energy Physics, School of Physics and Materials Science and Institute of Space Science and Technology, Nanchang University, 330031 Nanchang, Jiangxi, China
| | - P Zhou
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - R Zhou
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - X X Zhou
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - X X Zhou
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - B Y Zhu
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy and Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - C G Zhu
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - F R Zhu
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - H Zhu
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - K J Zhu
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - Y C Zou
- School of Physics, Huazhong University of Science and Technology, Wuhan 430074, Hubei, China
| | - X Zuo
- Key Laboratory of Particle Astrophysics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| |
Collapse
|
29
|
Hill LC, Rouce RH, Wu MJ, Wang T, Ma R, Zhang H, Mehta B, Lapteva N, Mei Z, Smith TS, Yang L, Srinivasan M, Burkhardt PM, Ramos CA, Lulla P, Arredondo M, Grilley B, Heslop HE, Brenner MK, Mamonkin M. Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas. Blood 2024; 143:1231-1241. [PMID: 38145560 PMCID: PMC10997912 DOI: 10.1182/blood.2023022204] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2023] [Revised: 11/15/2023] [Accepted: 11/27/2023] [Indexed: 12/27/2023] Open
Abstract
ABSTRACT Despite newer targeted therapies, patients with primary refractory or relapsed (r/r) T-cell lymphoma have a poor prognosis. The development of chimeric antigen receptor (CAR) T-cell platforms to treat T-cell malignancies often requires additional gene modifications to overcome fratricide because of shared T-cell antigens on normal and malignant T cells. We developed a CD5-directed CAR that produces minimal fratricide by downmodulating CD5 protein levels in transduced T cells while retaining strong cytotoxicity against CD5+ malignant cells. In our first-in-human phase 1 study (NCT0308190), second-generation autologous CD5.CAR T cells were manufactured from patients with r/r T-cell malignancies. Here, we report safety and efficacy data from a cohort of patients with mature T-cell lymphoma (TCL). Among the 17 patients with TCL enrolled, CD5 CAR T cells were successfully manufactured for 13 out of 14 attempted lines (93%) and administered to 9 (69%) patients. The overall response rate (complete remission or partial response) was 44%, with complete responses observed in 2 patients. The most common grade 3 or higher adverse events were cytopenias. No grade 3 or higher cytokine release syndrome or neurologic events occurred. Two patients died during the immediate toxicity evaluation period due to rapidly progressive disease. These results demonstrated that CD5.CAR T cells are safe and can induce clinical responses in patients with r/r CD5-expressing TCLs without eliminating endogenous T cells or increasing infectious complications. More patients and longer follow-up are needed for validation. This trial was registered at www.clinicaltrials.gov as #NCT0308190.
Collapse
Affiliation(s)
- LaQuisa C. Hill
- Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist Hospital, Houston, TX
- Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX
| | - Rayne H. Rouce
- Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist Hospital, Houston, TX
- Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX
- Department of Pediatrics, Baylor College of Medicine, Houston, TX
| | - Mengfen J. Wu
- Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist Hospital, Houston, TX
- Biostatistics Shared Resource, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX
| | - Tao Wang
- Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist Hospital, Houston, TX
- Biostatistics Shared Resource, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX
| | - Royce Ma
- Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist Hospital, Houston, TX
| | - Huimin Zhang
- Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX
| | - Birju Mehta
- Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX
| | - Natalia Lapteva
- Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX
| | - Zhuyong Mei
- Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX
| | - Tyler S. Smith
- Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist Hospital, Houston, TX
| | - Lina Yang
- Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist Hospital, Houston, TX
| | - Madhuwanti Srinivasan
- Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist Hospital, Houston, TX
| | - Phillip M. Burkhardt
- Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist Hospital, Houston, TX
| | - Carlos A. Ramos
- Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist Hospital, Houston, TX
- Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX
| | - Premal Lulla
- Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist Hospital, Houston, TX
- Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX
| | - Martha Arredondo
- Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist Hospital, Houston, TX
| | - Bambi Grilley
- Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist Hospital, Houston, TX
| | - Helen E. Heslop
- Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist Hospital, Houston, TX
- Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX
- Department of Pediatrics, Baylor College of Medicine, Houston, TX
| | - Malcolm K. Brenner
- Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist Hospital, Houston, TX
- Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX
- Department of Pediatrics, Baylor College of Medicine, Houston, TX
| | - Maksim Mamonkin
- Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist Hospital, Houston, TX
- Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX
| |
Collapse
|
30
|
Li S, Song H, Sun Y, Sun Y, Zhang H, Gao Z. Inhibition of soluble epoxide hydrolase as a therapeutic approach for blood-brain barrier dysfunction. Biochimie 2024; 223:13-22. [PMID: 38531484 DOI: 10.1016/j.biochi.2024.03.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2024] [Revised: 03/20/2024] [Accepted: 03/23/2024] [Indexed: 03/28/2024]
Abstract
The blood-brain barrier (BBB) is a protective semi-permeable structure that regulates the exchange of biomolecules between the peripheral blood and the central nervous system (CNS). Due to its specialized tight junctions and low vesicle trafficking, the BBB strictly limits the paracellular passage and transcellular transport of molecules to maintain the physiological condition of brain tissues. BBB breakdown is associated with many CNS disorders. Soluble epoxide hydrolase (sEH) is a hydrolase enzyme that converts epoxy-fatty acids (EpFAs) to their corresponding diols and is involved in the onset and progression of multiple diseases. EpFAs play a protective role in the central nervous system via preventing neuroinflammation, making sEH a potential therapeutic target for CNS diseases. Recent studies showed that sEH inhibition prevented BBB impairment caused by stroke, hemorrhage, traumatic brain injury, hyperglycemia and sepsis via regulating the expression of tight junctions. In this review, the protective actions of sEH inhibition on BBB and potential mechanisms are summarized, and some important questions that remain to be resolved are also addressed.
Collapse
Affiliation(s)
- Shuo Li
- Hebei Province Key Laboratory of Molecular Chemistry for Drug, School of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang, Hebei, China
| | - Huijia Song
- Hebei Province Key Laboratory of Molecular Chemistry for Drug, School of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang, Hebei, China
| | - Yanping Sun
- Hebei Province Key Laboratory of Molecular Chemistry for Drug, School of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang, Hebei, China
| | - Yongjun Sun
- Hebei Province Key Laboratory of Molecular Chemistry for Drug, School of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang, Hebei, China
| | - Huimin Zhang
- Hebei Province Key Laboratory of Molecular Chemistry for Drug, School of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang, Hebei, China
| | - Zibin Gao
- Hebei Province Key Laboratory of Molecular Chemistry for Drug, School of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang, Hebei, China.
| |
Collapse
|
31
|
Li J, Han T, Liu K, Shen Z, Daba NA, Tadesse KA, Khan MN, Shah A, Wang Z, Zhang H. Optimizing potassium and nitrogen fertilizer strategies to mitigate greenhouse gas emissions in global agroecosystems. Sci Total Environ 2024; 916:170270. [PMID: 38278248 DOI: 10.1016/j.scitotenv.2024.170270] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/31/2023] [Revised: 12/31/2023] [Accepted: 01/16/2024] [Indexed: 01/28/2024]
Abstract
The efficient management of fertilizer application in agriculture is vital for both food security and mitigating greenhouse gas (GHG) emissions. However, as potassium fertilizer (KF) is an essential soil nutrient, its impact on soil GHG emissions has received little attention. To address this knowledge gap and identify key determinants of GHG emissions, we conducted a comprehensive meta-analysis of 205 independent experiments conducted worldwide. Our results revealed that, in comparison to sole nitrogen fertilizer (NF) application, the concurrent use of KF elevated nitrous oxide (N2O) and methane (CH4) emissions by 39.5 % and 21.1 %, respectively, while concurrently reducing carbon dioxide (CO2) emissions by 8.1 %. The ratio of nitrogen and potassium fertilizer input (NF/KF) is identified as the primary factor explaining the variation in N2O emissions, whereas the type of KF plays a crucial role in determining CH4 and CO2 emissions. We observed a significant negative correlation between the NF/KF ratio and response ratios of N2O and CH4 emissions and a positive correlation with CO2 emissions response ratios. Furthermore, our findings indicate that when the NF/KF ratio surpasses 1.97, 4.61, and 3.78, respectively, the impact of KF on reducing N2O, CH4, and CO2 emissions stabilizes. Overall, our results underscore that the global integration of KF into agricultural practices significantly influences N2O and CH4 emissions, while simultaneously reducing CO2 emissions at a large scale. These findings provide a foundational framework and practical guidance for optimizing fertilizer application in the development of GHG emission reduction models.
Collapse
Affiliation(s)
- Jiwen Li
- State Key Laboratory of Efficient Utilization of Arid and Semi-arid Arable Land in Northern China, Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences, Beijing 100081, China
| | - Tianfu Han
- School of Agricultural Sciences, Zhengzhou University, Zhengzhou 450001, China
| | - Kailou Liu
- Jiangxi Institute of Red Soil and Germplasm Resources, Key Laboratory of Acidified Soil Amelioration and Utilization, Ministry of Agriculture and Rural Affairs, P. R. Jinxian, Jiangxi 331717, China
| | - Zhe Shen
- State Key Laboratory of Efficient Utilization of Arid and Semi-arid Arable Land in Northern China, Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences, Beijing 100081, China
| | - Nano Alemu Daba
- State Key Laboratory of Efficient Utilization of Arid and Semi-arid Arable Land in Northern China, Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences, Beijing 100081, China; School of Plant Sciences, Haramaya University, P.O. Box 138, Dire Dawa, Ethiopia
| | - Kiya Adare Tadesse
- State Key Laboratory of Efficient Utilization of Arid and Semi-arid Arable Land in Northern China, Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences, Beijing 100081, China; School of Plant Sciences, Haramaya University, P.O. Box 138, Dire Dawa, Ethiopia
| | - Muhammad Numan Khan
- State Key Laboratory of Efficient Utilization of Arid and Semi-arid Arable Land in Northern China, Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences, Beijing 100081, China
| | - Asad Shah
- State Key Laboratory of Efficient Utilization of Arid and Semi-arid Arable Land in Northern China, Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences, Beijing 100081, China
| | - Zhufeng Wang
- State Key Laboratory of Efficient Utilization of Arid and Semi-arid Arable Land in Northern China, Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences, Beijing 100081, China
| | - Huimin Zhang
- State Key Laboratory of Efficient Utilization of Arid and Semi-arid Arable Land in Northern China, Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences, Beijing 100081, China; Qiyang Farmland Ecosystem National Observation and Research Station, Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences, Qiyang, Hunan 426182, China.
| |
Collapse
|
32
|
Li JX, Li ZJ, Zhang HM, Xu SS, Quan RZ, Zhang H, Lu MM, Wang XY, Ma S, Mi J, Ding H, Li XL. [The association between portal vein thrombosis and rebleeding after non-urgent endoscopic treatment of esophagogastric varices]. Zhonghua Yi Xue Za Zhi 2024; 104:682-689. [PMID: 38418167 DOI: 10.3760/cma.j.cn112137-20231110-01064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 03/01/2024]
Abstract
Objective: To investigate the association between portal vein thrombosis and rebleeding after non-urgent endoscopic treatment of esophagogastric varices. Methods: The cirrhotic patients with esophagogastric varices diagnosed in the People's Hospital of Zhengzhou University from January 2017 to March 2023 were retrospectively collected. The patients were divided into thrombotic group and non-thrombotic group according to the presence or absence of portal vein thrombosis. The failure rate of endoscopic treatment and rebleeding rate in different periods were compared between the two groups. Receiver operating characteristic (ROC) curve was used to select the best cutoff value of gastric varicose diameter that affected total rebleeding during follow-up in both groups. The influencing factors of rebleeding within 12 and 36 months in both groups were analyzed, and the influencing factors of rebleeding within 36 months in thrombus group were further analyzed. Results: A total of 106 patients were enrolled, including 53 patients in the thrombotic group [male 37, female 16, aged 18-78 (54±13) years] and 53 patients in the non-thrombotic group [male 37, female 16, aged 27-83 (55±12) years]. The follow-up time of the two groups were (20±15) and (25±15) months, respectively. The total rebleeding rate in the thrombotic group was higher than that in the non-thrombotic group [30.2% (16/53) vs 13.2% (7/53), P˂0.05]. The rebleeding rates within 6, 12, 24 and 36 months in the thrombotic group were higher than those in the non-thrombotic group [18.9% (10/53) vs 5.7% (3/53), 18.9% (10/53) vs 5.7% (3/53), 28.3% (15/53) vs 9.4% (5/53), 30.2% (16/53) vs 11.3% (6/53), all P˂0.05]. The best cut-off value of the diameter of gastric varices that affects the total rebleeding in the two groups was 10.4 mm (10 mm was selected as the best cut-off value for the convenience of practical clinical application). Hemoglobin ˂ 85 g/L (HR=0.202, 95%CI: 0.043-0.953, P=0.043), 10 mm ˂ the diameter of GV ≤ 15 mm (HR=5.321, 95%CI: 1.161-24.390, P=0.031) and endoscopic variceal ligation combined with endoscopic tissue adhesive injection (EVL+ETAI) (HR=7.172, 95%CI: 1.910-26.930, P=0.004) were the risk factors for the first gastroesophageal variceal rebleeding within 12 months after non-urgent endoscopic treatment. EVL+ETAI (HR=3.811, 95%CI: 1.441-10.084, P=0.007) and portal vein thrombosis (HR=4.026, 95%CI: 1.483-10.932, P=0.006) were the risk factors for the first gastroesophageal variceal rebleeding within 36 months after non-urgent endoscopic treatment. The study found that, 10 mm ˂ the diameter of GV ≤ 15 mm (HR=7.503, 95%CI: 1.568-35.890, P=0.012) was the risk factor for rebleeding within 36 months in the thrombotic group. Conclusion: Portal vein thrombosis is a risk factor for rebleeding after non-urgent endoscopic treatment of esophagogastric varices.
Collapse
Affiliation(s)
- J X Li
- Department of Gastroenterology, People's Hospital of Zhengzhou University, Zhengzhou 450003, China
| | - Z J Li
- Department of Gastroenterology, Henan Provincial People's Hospital, Zhengzhou 450003, China
| | - H M Zhang
- Department of Gastroenterology, Henan Provincial People's Hospital, Zhengzhou 450003, China
| | - S S Xu
- Department of Gastroenterology, Henan Provincial People's Hospital, Zhengzhou 450003, China
| | - R Z Quan
- Department of Gastroenterology, People's Hospital of Zhengzhou University, Zhengzhou 450003, China
| | - H Zhang
- Department of Gastroenterology, People's Hospital of Zhengzhou University, Zhengzhou 450003, China
| | - M M Lu
- Department of Gastroenterology, People's Hospital of Zhengzhou University, Zhengzhou 450003, China
| | - X Y Wang
- Department of Gastroenterology, People's Hospital of Zhengzhou University, Zhengzhou 450003, China
| | - S Ma
- Department of Gastroenterology, People's Hospital of Zhengzhou University, Zhengzhou 450003, China
| | - J Mi
- Department of Gastroenterology, People's Hospital of Zhengzhou University, Zhengzhou 450003, China
| | - H Ding
- Department of Gastroenterology, Henan Provincial People's Hospital, Zhengzhou 450003, China
| | - X L Li
- Department of Gastroenterology, Henan Provincial People's Hospital, Zhengzhou 450003, China
| |
Collapse
|
33
|
Liu H, Jin Y, Huang L, Miao C, Tang J, Zhang H, Yin H, Lu X, Li N, Dai S, Gentile A, Zhang L, Sheng L. Transcriptomics and metabolomics reveal the underlying mechanism of drought treatment on anthocyanin accumulation in postharvest blood orange fruit. BMC Plant Biol 2024; 24:160. [PMID: 38429733 PMCID: PMC10908157 DOI: 10.1186/s12870-024-04868-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/18/2024] [Accepted: 02/27/2024] [Indexed: 03/03/2024]
Abstract
BACKGROUND Anthocyanins are the most important compounds for nutritional quality and economic values of blood orange. However, there are few reports on the pre-harvest treatment accelerating the accumulation of anthocyanins in postharvest blood orange fruit. Here, we performed a comparative transcriptome and metabolomics analysis to elucidate the underlying mechanism involved in seasonal drought (SD) treatment during the fruit expansion stage on anthocyanin accumulation in postharvest 'Tarocco' blood orange fruit. RESULTS Our results showed that SD treatment slowed down the fruit enlargement and increased the sugar accumulation during the fruit development and maturation period. Obviously, under SD treatment, the accumulation of anthocyanin in blood orange fruit during postharvest storage was significantly accelerated and markedly higher than that in CK. Meanwhile, the total flavonoids and phenols content and antioxidant activity in SD treatment fruits were also sensibly increased during postharvest storage. Based on metabolome analysis, we found that substrates required for anthocyanin biosynthesis, such as amino acids and their derivatives, and phenolic acids, had significantly accumulated and were higher in SD treated mature fruits compared with that of CK. Furthermore, according to the results of the transcriptome data and weighted gene coexpression correlation network analysis (WGCNA) analysis, phenylalanine ammonia-lyase (PAL3) was considered a key structural gene. The qRT-PCR analysis verified that the PAL3 was highly expressed in SD treated postharvest stored fruits, and was significantly positively correlated with the anthocyanin content. Moreover, we found that other structural genes in the anthocyanin biosynthesis pathway were also upregulated under SD treatment, as evidenced by transcriptome data and qRT-PCR analysis. CONCLUSIONS The findings suggest that SD treatment promotes the accumulation of substrates necessary for anthocyanin biosynthesis during the fruit ripening process, and activates the expression of anthocyanin biosynthesis pathway genes during the postharvest storage period. This is especially true for PAL3, which co-contributed to the rapid accumulation of anthocyanin. The present study provides a theoretical basis for the postharvest quality control and water-saving utilization of blood orange fruit.
Collapse
Affiliation(s)
- Hongbin Liu
- National Center for Citrus Improvement Changsha, College of Horticulture, Hunan Agricultural University, Changsha, 410128, China
| | - Yan Jin
- National Center for Citrus Improvement Changsha, College of Horticulture, Hunan Agricultural University, Changsha, 410128, China
| | - Le Huang
- National Center for Citrus Improvement Changsha, College of Horticulture, Hunan Agricultural University, Changsha, 410128, China
| | - Chouyu Miao
- National Center for Citrus Improvement Changsha, College of Horticulture, Hunan Agricultural University, Changsha, 410128, China
| | - Jiayi Tang
- National Center for Citrus Improvement Changsha, College of Horticulture, Hunan Agricultural University, Changsha, 410128, China
| | - Huimin Zhang
- National Center for Citrus Improvement Changsha, College of Horticulture, Hunan Agricultural University, Changsha, 410128, China
| | - Haojie Yin
- National Center for Citrus Improvement Changsha, College of Horticulture, Hunan Agricultural University, Changsha, 410128, China
| | - Xiaopeng Lu
- National Center for Citrus Improvement Changsha, College of Horticulture, Hunan Agricultural University, Changsha, 410128, China
| | - Na Li
- National Center for Citrus Improvement Changsha, College of Horticulture, Hunan Agricultural University, Changsha, 410128, China
| | - Suming Dai
- National Center for Citrus Improvement Changsha, College of Horticulture, Hunan Agricultural University, Changsha, 410128, China
| | - Alessandra Gentile
- National Center for Citrus Improvement Changsha, College of Horticulture, Hunan Agricultural University, Changsha, 410128, China
- Department of Agriculture and Food Science, University of Catania, Catania, 95123, Italy
| | - Ling Zhang
- Agriculture and Rural Bureau of Mayang Miao Autonomous County, Huaihua, China
| | - Ling Sheng
- National Center for Citrus Improvement Changsha, College of Horticulture, Hunan Agricultural University, Changsha, 410128, China.
| |
Collapse
|
34
|
Qu X, Song Y, Li Q, Xu Q, Li Y, Zhang H, Cheng X, Mackay CR, Wang Q, Liu W. Indole-3-acetic acid ameliorates dextran sulfate sodium-induced colitis via the ERK signaling pathway. Arch Pharm Res 2024; 47:288-299. [PMID: 38489148 DOI: 10.1007/s12272-024-01488-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2023] [Accepted: 03/06/2024] [Indexed: 03/17/2024]
Abstract
Microbiota-derived catabolism of nutrients is closely related to ulcerative colitis (UC). The level of indole-3-acetic acid (IAA), a microbiota-dependent metabolite of tryptophan, was decreased significantly in the feces of UC patients. Thus supplementation with IAA could be a potential therapeutic method for ameliorating colitis. In this work, the protective effect of supplementation with IAA on dextran sulfate sodium (DSS)-induced colitis was evaluated, and the underlying mechanism was elucidated. The results indicated that the administration of IAA significantly relieved DSS-induced weight loss, reduced the disease activity index (DAI), restored colon length, alleviated intestinal injury, and improved the intestinal tight junction barrier. Furthermore, IAA inhibited intestinal inflammation by reducing the expression of proinflammatory cytokines and promoting the production of IL-10 and TGF-β1. In addition, the ERK signaling pathway is an important mediator of various physiological processes including inflammatory responses and is closely associated with the expression of IL-10. Notably, IAA treatment induced the activation of extracellular signal-regulated kinase (ERK), which is involved in the progression of colitis, while the ERK inhibitor U0126 attenuated the beneficial effects of IAA. In summary, IAA could attenuate the clinical symptoms of colitis, and the ERK signaling pathway was involved in the underlying mechanism. Supplementation with IAA could be a potential option for preventing or ameliorating UC.
Collapse
Affiliation(s)
- Xinyan Qu
- Key Laboratory for Natural Active Pharmaceutical Constituents Research in Universities of Shandong Province, School of Pharmaceutical Sciences, Shandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan, China
| | - Yingying Song
- Key Laboratory for Natural Active Pharmaceutical Constituents Research in Universities of Shandong Province, School of Pharmaceutical Sciences, Shandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan, China
| | - Qingjun Li
- Experimental Center, Shandong University of Traditional Chinese Medicine, Jinan, China
| | - Qi Xu
- Key Laboratory for Natural Active Pharmaceutical Constituents Research in Universities of Shandong Province, School of Pharmaceutical Sciences, Shandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan, China
| | - Yanru Li
- Key Laboratory for Natural Active Pharmaceutical Constituents Research in Universities of Shandong Province, School of Pharmaceutical Sciences, Shandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan, China
| | - Huimin Zhang
- Shandong Academy of Chinese Medicine, Jinan, China
| | - Xuemei Cheng
- Shandong Center for Disease Control and Prevention, Jinan, China
| | - Charles R Mackay
- Key Laboratory for Natural Active Pharmaceutical Constituents Research in Universities of Shandong Province, School of Pharmaceutical Sciences, Shandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan, China
| | - Quanbo Wang
- Key Laboratory for Natural Active Pharmaceutical Constituents Research in Universities of Shandong Province, School of Pharmaceutical Sciences, Shandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan, China.
| | - Wei Liu
- Key Laboratory for Natural Active Pharmaceutical Constituents Research in Universities of Shandong Province, School of Pharmaceutical Sciences, Shandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan, China.
| |
Collapse
|
35
|
Zhu X, Huang JY, Dong WY, Tang HD, Xu S, Wu Q, Zhang H, Cheng PK, Jin Y, Zhu MY, Zhao W, Mao Y, Wang H, Zhang Y, Wang H, Tao W, Tian Y, Bai L, Zhang Z. Somatosensory cortex and central amygdala regulate neuropathic pain-mediated peripheral immune response via vagal projections to the spleen. Nat Neurosci 2024; 27:471-483. [PMID: 38291284 DOI: 10.1038/s41593-023-01561-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2022] [Accepted: 12/13/2023] [Indexed: 02/01/2024]
Abstract
Pain involves neuroimmune crosstalk, but the mechanisms of this remain unclear. Here we showed that the splenic T helper 2 (TH2) immune cell response is differentially regulated in male mice with acute versus chronic neuropathic pain and that acetylcholinergic neurons in the dorsal motor nucleus of the vagus (AChDMV) directly innervate the spleen. Combined in vivo recording and immune cell profiling revealed the following two distinct circuits involved in pain-mediated peripheral TH2 immune response: glutamatergic neurons in the primary somatosensory cortex (GluS1HL)→AChDMV→spleen circuit and GABAergic neurons in the central nucleus of the amygdala (GABACeA)→AChDMV→spleen circuit. The acute pain condition elicits increased excitation from GluS1HL neurons to spleen-projecting AChDMV neurons and increased the proportion of splenic TH2 immune cells. The chronic pain condition increased inhibition from GABACeA neurons to spleen-projecting AChDMV neurons and decreased splenic TH2 immune cells. Our study thus demonstrates how the brain encodes pain-state-specific immune responses in the spleen.
Collapse
Affiliation(s)
- Xia Zhu
- Department of Anesthesiology, The First Affiliated Hospital of USTC, Hefei National Laboratory for Physical Sciences at the Microscale, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, P. R. China
| | - Ji-Ye Huang
- Department of Anesthesiology, The First Affiliated Hospital of USTC, Hefei National Laboratory for Physical Sciences at the Microscale, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, P. R. China
| | - Wan-Ying Dong
- Department of Anesthesiology, The First Affiliated Hospital of USTC, Hefei National Laboratory for Physical Sciences at the Microscale, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, P. R. China
| | - Hao-Di Tang
- Department of Anesthesiology, The First Affiliated Hospital of USTC, Hefei National Laboratory for Physical Sciences at the Microscale, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, P. R. China
- Laboratory of Anesthesia and Critical Care Medicine, National-Local Joint Engineering Research Center of Translational Medicine of Anesthesiology, West China Hospital, Sichuan University, Chengdu, P. R. China
| | - Si Xu
- Department of Neurology, The Second Affiliated Hospital of Anhui Medical University, Hefei, P. R. China
| | - Qielan Wu
- Department of Oncology, The First Affiliated Hospital of USTC, CAS Key Laboratory of Innate Immunity and Chronic Disease, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, P. R. China
| | - Huimin Zhang
- Department of Oncology, The First Affiliated Hospital of USTC, CAS Key Laboratory of Innate Immunity and Chronic Disease, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, P. R. China
| | - Ping-Kai Cheng
- Department of Anesthesiology, The First Affiliated Hospital of USTC, Hefei National Laboratory for Physical Sciences at the Microscale, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, P. R. China
| | - Yuxin Jin
- Department of Anesthesiology, The First Affiliated Hospital of USTC, Hefei National Laboratory for Physical Sciences at the Microscale, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, P. R. China
| | - Meng-Yu Zhu
- College & Hospital of Stomatology, Anhui Medical University, Key Laboratory of Oral Diseases Research of Anhui Province, Hefei, P. R. China
- Department of Physiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, P. R. China
| | - Wan Zhao
- Department of Otolaryngology-Head and Neck Surgery, The First Affiliated Hospital of University of Science and Technique of China, Hefei, P. R. China
| | - Yu Mao
- Department of Anesthesiology, The First Affiliated Hospital of USTC, Hefei National Laboratory for Physical Sciences at the Microscale, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, P. R. China
- Department of Anesthesiology and Pain Management, The First Affiliated Hospital of Anhui Medical University, Hefei, P. R. China
| | - Haitao Wang
- School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, P. R. China
| | - Yan Zhang
- Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, P. R. China
| | - Hao Wang
- Institute of Artificial Intelligence, Hefei Comprehensive National Science Center, Hefei, P. R. China
| | - Wenjuan Tao
- College & Hospital of Stomatology, Anhui Medical University, Key Laboratory of Oral Diseases Research of Anhui Province, Hefei, P. R. China.
- Department of Physiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, P. R. China.
| | - Yanghua Tian
- Department of Neurology, The Second Affiliated Hospital of Anhui Medical University, Hefei, P. R. China.
| | - Li Bai
- Department of Oncology, The First Affiliated Hospital of USTC, CAS Key Laboratory of Innate Immunity and Chronic Disease, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, P. R. China.
| | - Zhi Zhang
- Department of Anesthesiology, The First Affiliated Hospital of USTC, Hefei National Laboratory for Physical Sciences at the Microscale, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, P. R. China.
- Department of Biophysics and Neurobiology, CAS Key Laboratory of Brain Function and Disease, University of Science and Technology of China, Hefei, P. R. China.
- The Center for Advanced Interdisciplinary Science and Biomedicine, Institute of Health and Medicine, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, P. R. China.
| |
Collapse
|
36
|
Hao J, Du Z, Bo Z, Zhang H, Wang X. Impact of Metabolic Syndrome on Post-Operative Infection in Patients Undergoing Flexible Ureteroscopy Lithotripsy. Surg Infect (Larchmt) 2024; 25:140-146. [PMID: 38265838 DOI: 10.1089/sur.2023.205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2024] Open
Abstract
Background: To investigate retrospectively whether metabolic syndrome (MetS) of flexible ureteroscopy (fURS) lithotripsy can be used to predict post-operative infection. Patients and Methods: After screening, 1,110 patients who received fURS lithotripsy for upper urinary tract stones in our center between January 2015 and December 2022 were analyzed retrospectively. Patients were divided into MetS-positive group and MetS-negative group. Post-operative infection was divided into fever, urosepsis, and septic shock. Relevant data during the peri-operative period were collected. Univariable and multivariable logistic regression analyses were adopted to estimate the impact of metabolic syndrome on post-operative infection in patients undergoing fURS lithotripsy. Results: Among the 1,110 patients, 427 tested positive for MetS, whereas 683 tested negative. Eighty-eight patients suffered from fever (67 patients in the MetS-positive group and 21 in the MetS-negative group). Forty-nine patients had urosepsis (29 patients in the MetS-positive group and 20 in the MetS-negative group), of whom seven patients developed septic shock. No patient developed multiple organ failure or died because of infection. The prevalence of post-operative infections in the MetS-positive group was higher than that in the MetS-negative group (p < 0.001). Multivariable logistic regression analyses showed that diabetes mellitus, MetS-positive, positive urine culture, and longer operation time were positively correlated with post-operative fever. Positive MetS, positive urine culture, and longer operation time were strongly correlated with post-operative urosepsis. Conclusions: Metabolic syndrome was found to be associated with post-operative infection in patients undergoing fURS lithotripsy, suggesting it can serve as a predictive factor.
Collapse
Affiliation(s)
- Junxiu Hao
- Department of Urology, Tangshan Gongren Hospital, Lubei District, Tangshan, Hebei Province, People's Republic of China
| | - Zhiyong Du
- Department of Urology Surgery, Dingzhou People's Hospital, Dingzhou, Hebei Province, People's Republic of China
| | - Zhiqiang Bo
- Department of Urology, Tangshan Gongren Hospital, Lubei District, Tangshan, Hebei Province, People's Republic of China
| | - Huimin Zhang
- Department of Urology, Tangshan Gongren Hospital, Lubei District, Tangshan, Hebei Province, People's Republic of China
| | - Xiuyun Wang
- Department of Urology, Tangshan Gongren Hospital, Lubei District, Tangshan, Hebei Province, People's Republic of China
| |
Collapse
|
37
|
Shen F, Gao C, Wang M, Ding X, Zhao H, Zhou M, Mao J, Kuai L, Li B, Wang D, Zhang H, Ma X. Therapeutic effects of the Qingre-Qushi recipe on atopic dermatitis through the regulation of gut microbiota and skin inflammation. Heliyon 2024; 10:e26063. [PMID: 38380039 PMCID: PMC10877368 DOI: 10.1016/j.heliyon.2024.e26063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2023] [Revised: 02/06/2024] [Accepted: 02/07/2024] [Indexed: 02/22/2024] Open
Abstract
Accumulating evidence has highlighted a strong association between gut microbiota and the occurrence, development, prevention, and treatment of atopic dermatitis (AD). The regulation of gut microbial dysbiosis by oral traditional Chinese medicine (TCM) has garnered significant attention. In the treatment of AD, the TCM formula Qingre-Qushi Recipe (QRQS) has demonstrated clinical efficacy. However, both the therapeutic mechanisms of QRQS and its impact on gut microbiota remain unclear. Thus, our study aimed to assess the efficacy of QRQS and evaluate its influence on the composition and diversity of gut microbiota in AD animal models. First, we investigated the therapeutic effect of QRQS on AD using two animal models: filaggrin-deficient mice (Flaky tail, ft/ft) and MC903-induced AD-like mice. Subsequently, we explored its influence on the composition and diversity of gut microbiota. Our results demonstrated that QRQS treatment ameliorated the symptoms in both ft/ft mice and MC903-induced AD-like mice. It also reduced the levels of serum IgE and pro-inflammatory cytokines, including IL-1β, IL-4, IL-5, IL-9, IL-13, IL-17A, and TNF-α. Furthermore, QRQS remarkably regulated gut microbiota diversity by increasing Lactobacillaceae and decreasing Bacteroidales. The inflammatory factors in peripheral serum of ft/ft mice showed a close correlation with gut microbiota, as determined using the Spearman correlation coefficient. Additionally, PICRUSt analysis revealed an enrichment in ascorbate and aldarate metabolism, fatty acid metabolism and biosynthesis, and propanoate metabolism in the QRQS group compared to the ft/ft group. Finally, we identified liquiritin as the primary active ingredient of QRQS using ultra-high-performance liquid chromatography-high-resolution mass spectrometry (UPLC-HRMS). Our findings revealed that QRQS improved AD-like symptoms and alleviated skin inflammation in ft/ft and MC903-induced mice. This suggests that modulating the gut microbiota may help elucidate its anti-inflammation activation mechanism, highlighting a new therapeutic strategy that targets the intestinal flora to prevent and treat AD.
Collapse
Affiliation(s)
- Fang Shen
- Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, China
| | - Chunjie Gao
- Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, China
| | - Mingxia Wang
- Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, China
| | - Xiaojie Ding
- Institute of Dermatology, Shanghai Academy of Traditional Chinese Medicine, Shanghai, 201203, China
- Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, China
| | - Hang Zhao
- Institute of Dermatology, Shanghai Academy of Traditional Chinese Medicine, Shanghai, 201203, China
- Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, China
| | - Mi Zhou
- Institute of Dermatology, Shanghai Academy of Traditional Chinese Medicine, Shanghai, 201203, China
- Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, China
| | - Jingyi Mao
- Department of Dermatology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China
| | - Le Kuai
- Institute of Dermatology, Shanghai Academy of Traditional Chinese Medicine, Shanghai, 201203, China
- Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, China
| | - Bin Li
- Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, China
- Institute of Dermatology, Shanghai Academy of Traditional Chinese Medicine, Shanghai, 201203, China
- Institute of Dermatology, School of Medicine, Tongji University, Shanghai, 200443, China
| | - Dongming Wang
- Department of Dermatology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China
| | - Huimin Zhang
- Department of Dermatology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China
| | - Xin Ma
- Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, China
- Department of Dermatology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China
- Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, China
| |
Collapse
|
38
|
Liu X, Hao S, Bian J, Lou Y, Zhang H, Wu H, Cai J, Ma W. Performance of aldosterone-to-renin ratio before washout of antihypertensive drugs in screening of primary aldosteronism. J Clin Endocrinol Metab 2024:dgae094. [PMID: 38381080 DOI: 10.1210/clinem/dgae094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/02/2023] [Revised: 01/22/2024] [Accepted: 02/14/2024] [Indexed: 02/22/2024]
Abstract
OBJECTIVE The aim of this study is to evaluate performance of aldosterone-to-renin ratio (ARR) before washout of antihypertensive drugs as a screening test for primary aldosteronism (PA). METHODS This retrospective analysis included consecutive patients suspected of having secondary hypertension during a period from January 2017 to May 2022 at authors' institute. For inclusion in the final analysis, ARR must be available prior to as well as after discontinuation of antihypertensives. Patients with ARR ≥2.4(ng/dL)/(μIU/mL) after washout proceeded to confirmatory tests. Diagnosis of PA was established based on positive result of the confirmatory test. Diagnostic accuracy of ARR prior to the washout in predicting PA are shown as sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV). RESULTS The analysis included a total of 1306 patients [median age of 50.2 (41.0-59.0) years, 64.0% male]. Confirmatory tests showed PA in 215(16.5%) patients and essential hypertension (EH) in the remaining 1091(83.5%) patients. In comparison to the second screening test, the first screening test (before washout of antihypertensives) yielded lower plasma aldosterone and higher renin, and consequently lower ARR in both the PA and EH groups. At a cutoff of 0.7(ng/dL)/(μIU/ml), ARR before washout had 96.3% sensitivity, 61.2% specificity, 0.33 PPV and 0.99 NPV. At a lower cutoff of 0.5(ng/dL)/(μIU/ml), the sensitivity, specificity, PPV and NPV are 97.7%, 52.0%, 0.29 and 0.99. CONCLUSIONS ARR prior to washout of antihypertensives is a sensitive screening test for PA. Washout of antihypertensives could be omitted and further investigation for PA is not warranted if ARR was ≤ 0.7(ng/dL)/(μIU/ml) before washout.
Collapse
Affiliation(s)
- Xinyu Liu
- Hypertension Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China
| | - Sufang Hao
- Hypertension Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China
| | - Jin Bian
- Hypertension Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China
| | - Ying Lou
- Hypertension Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China
| | - Huimin Zhang
- Hypertension Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China
| | - Haiying Wu
- Hypertension Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China
| | - Jun Cai
- Hypertension Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China
| | - Wenjun Ma
- Hypertension Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China
| |
Collapse
|
39
|
Zheng J, Li N, Li X, Han Y, Lv X, Zhang H, Ren L. The Nuclear Localization Signal of Porcine Circovirus Type 4 Affects the Subcellular Localization of the Virus Capsid and the Production of Virus-like Particles. Int J Mol Sci 2024; 25:2459. [PMID: 38473709 DOI: 10.3390/ijms25052459] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2023] [Revised: 01/29/2024] [Accepted: 02/18/2024] [Indexed: 03/14/2024] Open
Abstract
Porcine circovirus 4 (PCV4) is a newly identified virus belonging to PCV of the Circoviridae family, the Circovirus genus. We previously found that PCV4 is pathogenic in vitro, while the virus's replication in cells is still unknown. In this study, we evaluated the N-terminal of the PCV4 capsid (Cap) and identified an NLS at amino acid residues 4-37 of the N-terminus of the PCV4 Cap, 4RSRYSRRRRNRRNQRRRGLWPRASRRRYRWRRKN37. The NLS was further divided into two fragments (NLS-A and NLS-B) based on the predicted structure, including two α-helixes, which were located at 4RSRYSRRRRNRRNQRR19 and 24PRASRRRYRWRRK36, respectively. Further studies showed that the NLS, especially the first α-helixes formed by the NLS-A fragment, determined the nuclear localization of the Cap protein, and the amino acid 4RSRY7 in the NLS of the PCV4 Cap was the critical motif affecting the VLP packaging. These results will provide a theoretical basis for elucidating the infection mechanism of PCV4 and developing subunit vaccines based on VLPs.
Collapse
Affiliation(s)
- Jiawei Zheng
- College of Animal Sciences, Key Lab for Zoonoses Research, Ministry of Education, Jilin University, 5333 Xi'an Road, Changchun 130062, China
| | - Nan Li
- Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, 666 Liuying West Road, Changchun 130122, China
| | - Xue Li
- College of Animal Sciences, Key Lab for Zoonoses Research, Ministry of Education, Jilin University, 5333 Xi'an Road, Changchun 130062, China
| | - Yaqi Han
- College of Animal Sciences, Key Lab for Zoonoses Research, Ministry of Education, Jilin University, 5333 Xi'an Road, Changchun 130062, China
| | - Xinru Lv
- College of Animal Sciences, Key Lab for Zoonoses Research, Ministry of Education, Jilin University, 5333 Xi'an Road, Changchun 130062, China
| | - Huimin Zhang
- College of Animal Sciences, Key Lab for Zoonoses Research, Ministry of Education, Jilin University, 5333 Xi'an Road, Changchun 130062, China
| | - Linzhu Ren
- College of Animal Sciences, Key Lab for Zoonoses Research, Ministry of Education, Jilin University, 5333 Xi'an Road, Changchun 130062, China
- College of Veterinary Medicine, Yunnan Agricultural University, Kunming 650201, China
| |
Collapse
|
40
|
Zhang J, Shahbaz M, Ijaz M, Zhang H. Bibliometric analysis of antimalarial drug resistance. Front Cell Infect Microbiol 2024; 14:1270060. [PMID: 38410722 PMCID: PMC10895045 DOI: 10.3389/fcimb.2024.1270060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2023] [Accepted: 01/02/2024] [Indexed: 02/28/2024] Open
Abstract
Background Malaria has always been a serious infectious disease prevalent in the world. Antimalarial drugs such as chloroquine and artemisinin have been the main compounds used to treat malaria. However, the massive use of this type of drugs accelerates the evolution and spread of malaria parasites, leading to the development of resistance. A large number of related data have been published by researchers in recent years. CiteSpace software has gained popularity among us researchers in recent years, because of its ability to help us obtain the core information we want in a mass of articles. In order to analyze the hotspots and develop trends in this field through visual analysis, this study used CiteSpace software to summarize the available data in the literature to provide insights. Method Relevant literature was collected from the Web of Science Core Collection (WOSCC) from 1 January 2015 to 29 March 2023. CiteSpace software and Microsoft Excel were used to analyze and present the data, respectively. Results A total of 2,561 literatures were retrieved and 2,559 literatures were included in the analysis after the removal of duplicates. An irrefutable witness of the ever-growing interest in the topic of antimalarial drug resistance could be expressed by the exponentially increased number of publications and related citations from 2015 to 2022, and its sustained growth trend by 2023. During the past 7 years, USA, Oxford University, and David A Fidock are the country, institution, and author with the most publications in this field of research, respectively. We focused on the references and keywords from literature and found that the research and development of new drugs is the newest hotspot in this field. A growing number of scientists are devoted to finding new antimalarial drugs. Conclusion This study is the first visual metrological analysis of antimalarial drug resistance, using bibliometric methods. As a baseline information, it is important to analyze research output published globally on antimalarial drug resistance. In order to better understand the current research situation and future research plan agenda, such baseline data are needed accordingly.
Collapse
Affiliation(s)
- Jialu Zhang
- Shandong University of Traditional Chinese Medicine, College of Pharmacy, Jinan, China
- Shandong Academy of Chinese Medicine, Institute of Chinese medicine analysis, Jinan, China
| | - Muhammad Shahbaz
- Shandong Academy of Chinese Medicine, Institute of Chinese medicine analysis, Jinan, China
- Department of Radiology, Qilu Hospital Affiliated to Shandong University, Jinan, China
- Research Center for Sectional and Imaging Anatomy, Digital Human Institute, School of Basic Medical Science, Shandong University, Jinan, Shandong, China
| | - Muhammad Ijaz
- The Faculty of Medicine, Qilu Institute of Technology, Jinan, China
- Department of Pharmacology, School of Pharmaceutical Science, Shandong University, Jinan, China
| | - Huimin Zhang
- Shandong Academy of Chinese Medicine, Institute of Chinese medicine analysis, Jinan, China
| |
Collapse
|
41
|
Duan LL, Zhao YB, Er YL, Ye PP, Wang W, Gao X, Deng X, Jin Y, Wang Y, Ji CR, Ma XY, Gao C, Zhao YH, Zhu SQ, Su SZ, Guo XE, Peng JJ, Yu Y, Yang C, Su YY, Zhao M, Guo LH, Wu YP, Luo YN, Meng RL, Xu HF, Liu HZ, Ruan HH, Xie B, Zhang HM, Liao YH, Chen Y, Wang LH. [The effect of Ba Duan Jin on the balance of community-dwelling older adults: a cluster randomized control trial]. Zhonghua Liu Xing Bing Xue Za Zhi 2024; 45:250-256. [PMID: 38413065 DOI: 10.3760/cma.j.cn112338-20230506-00283] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/29/2024]
Abstract
Objective: To assess the effectiveness of a 6-month Ba Duan Jin exercise program in improving the balance of community-dwelling older adults. Methods: A two arms, parallel-group, cluster randomized controlled trial was conducted in 1 028 community residents aged 60-80 years in 40 communities in 5 provinces of China. Participants in the intervention group (20 communities, 523 people) received Ba Duan Jin exercise 5 days/week, 1 hour/day for 6 months, and three times of falls prevention health education, and the control group (20 communities, 505 people) received falls prevention health education same as the intervention group. The Berg balance scale (BBS) score was the leading outcome indicator, and the secondary outcome indicators included the length of time of standing on one foot (with eyes open and closed), standing in a tandem stance (with eyes open and closed), the closed circle test, and the timed up to test. Results: A total of 1 028 participants were included in the final analysis, including 731 women (71.11%) and 297 men (28.89%), and the age was (69.87±5.67) years. After the 3-month intervention, compared with the baseline data, the BBS score of the intervention group was significantly higher than the control group by 3.05 (95%CI: 2.23-3.88) points (P<0.001). After the 6-month intervention, compared with the baseline data, the BBS score of the intervention group was significantly higher than the control group by 4.70 (95%CI: 4.03-5.37) points (P<0.001). Ba Duan Jin showed significant improvement (P<0.05) in all secondary outcomes after 6 months of exercise in the intervention group compared with the control group. Conclusions: This study showed that Ba Duan Jin exercise can improve balance in community-dwelling older adults aged 60-80. The longer the exercise time, the better the improvement.
Collapse
Affiliation(s)
- L L Duan
- Division of Injury Prevention and Mental Health, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - Y B Zhao
- Shijiazhuang People's Hospital, Shijiazhuang 050031, China
| | - Y L Er
- Division of Injury Prevention and Mental Health, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - P P Ye
- Division of Injury Prevention and Mental Health, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - W Wang
- National Clinical Research Center for Cardiovascular Diseases/National Center for Cardiovascular Diseases/Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing 100037, China
| | - X Gao
- Office of Chronic Disease and Ageing Health Management, Chinese Center for Disease Control and Prevention, Beijing 102206, China
| | - X Deng
- Division of Injury Prevention and Mental Health, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - Y Jin
- Division of Injury Prevention and Mental Health, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - Y Wang
- Division of Injury Prevention and Mental Health, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - C R Ji
- Division of Injury Prevention and Mental Health, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - X Y Ma
- Institute for Chronic and Non-communicable Disease Control and Prevention, Shijiazhuang Municipal Center for Disease Control and Prevention, Shijiazhuang 050011, China
| | - C Gao
- Institute for Chronic and Non-communicable Disease Control and Prevention, Shijiazhuang Municipal Center for Disease Control and Prevention, Shijiazhuang 050011, China
| | - Y H Zhao
- Shijiazhuang Chang'an District Center for Disease Control and Prevention, Shijiazhuang 050011, China
| | - S Q Zhu
- Department of Chronic Prevention and Control, Shijiazhuang Chang'an District Center for Disease Control and Prevention, Shijiazhuang 050011, China
| | - S Z Su
- Department of Nursing, Shijiazhuang Hospital of Traditional Chinese Medicine, Shijiazhuang 050051, China
| | - X E Guo
- Department of Nursing, Shijiazhuang Hospital of Traditional Chinese Medicine, Shijiazhuang 050051, China
| | - J J Peng
- Department of Injury Control and Prevention, Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China
| | - Y Yu
- Department of Injury Control and Prevention, Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China
| | - C Yang
- Department of Cancer and Injury Control and Prevention, Shanghai Pudong New Area Center for Disease Control and Prevention, Shanghai 200136, China
| | - Y Y Su
- Department of Cancer and Injury Control and Prevention, Shanghai Pudong New Area Center for Disease Control and Prevention, Shanghai 200136, China
| | - M Zhao
- Department of Chronic and Non-communicable Disease Control and Prevention, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, China
| | - L H Guo
- Department of Chronic and Non-communicable Disease Control and Prevention, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, China
| | - Y P Wu
- General Office, Cixi Municipal Center for Disease Control and Prevention of Zhejiang Province, Ningbo 315302, China
| | - Y N Luo
- General Office, Cixi Municipal Center for Disease Control and Prevention of Zhejiang Province, Ningbo 315302, China
| | - R L Meng
- Department of Chronic and Non-communicable Disease Control and Prevention, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511483, China
| | - H F Xu
- Department of Chronic and Non-communicable Disease Control and Prevention, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511483, China
| | - H Z Liu
- Guangzhou Municipal Center for Disease Control and Prevention, Guangzhou 510440, China
| | - H H Ruan
- Department of Chronic and Non-communicable Disease Control and Prevention, Chronic Disease Prevention and Control Station of Guangzhou Panyu District, Guangzhou 511400, China
| | - B Xie
- Department of Psychiatric, Shenzhen Nanshan Center for Chronic Disease Control, Shenzhen 518054, China
| | - H M Zhang
- Department of Psychiatric, Shenzhen Nanshan Center for Chronic Disease Control, Shenzhen 518054, China
| | - Y H Liao
- Department of Psychiatric, Shenzhen Nanshan Center for Chronic Disease Control, Shenzhen 518054, China
| | - Y Chen
- Department of Psychiatric, Shenzhen Nanshan Center for Chronic Disease Control, Shenzhen 518054, China
| | - L H Wang
- Division of Injury Prevention and Mental Health, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| |
Collapse
|
42
|
Tian C, Wang Y, Su M, Huang Y, Zhang Y, Dou J, Zhao C, Cai Y, Pan J, Bai S, Wu Q, Chen S, Li S, Xie D, Lv R, Chen Y, Wang Y, Fu S, Zhang H, Bai L. Motility and tumor infiltration are key aspects of invariant natural killer T cell anti-tumor function. Nat Commun 2024; 15:1213. [PMID: 38332012 PMCID: PMC10853287 DOI: 10.1038/s41467-024-45208-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2023] [Accepted: 01/17/2024] [Indexed: 02/10/2024] Open
Abstract
Dysfunction of invariant natural killer T (iNKT) cells contributes to immune resistance of tumors. Most mechanistic studies focus on their static functional status before or after activation, not considering motility as an important characteristic for antigen scanning and thus anti-tumor capability. Here we show via intravital imaging, that impaired motility of iNKT cells and their exclusion from tumors both contribute to the diminished anti-tumor iNKT cell response. Mechanistically, CD1d, expressed on macrophages, interferes with tumor infiltration of iNKT cells and iNKT-DC interactions but does not influence their intratumoral motility. VCAM1, expressed by cancer cells, restricts iNKT cell motility and inhibits their antigen scanning and activation by DCs via reducing CDC42 expression. Blocking VCAM1-CD49d signaling improves motility and activation of intratumoral iNKT cells, and consequently augments their anti-tumor function. Interference with macrophage-iNKT cell interactions further enhances the anti-tumor capability of iNKT cells. Thus, our findings provide a direction to enhance the efficacy of iNKT cell-based immunotherapy via motility regulation.
Collapse
Affiliation(s)
- Chenxi Tian
- Hefei national Research Center for Physical Sciences at the Microscale, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
| | - Yu Wang
- Hefei national Research Center for Physical Sciences at the Microscale, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
| | - Miya Su
- Hefei national Research Center for Physical Sciences at the Microscale, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
| | - Yuanyuan Huang
- Hefei national Research Center for Physical Sciences at the Microscale, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
| | - Yuwei Zhang
- Hefei national Research Center for Physical Sciences at the Microscale, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
| | - Jiaxiang Dou
- Institute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei, China
| | - Changfeng Zhao
- Hefei national Research Center for Physical Sciences at the Microscale, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
| | - Yuting Cai
- Hefei national Research Center for Physical Sciences at the Microscale, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
| | - Jun Pan
- Hefei national Research Center for Physical Sciences at the Microscale, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
| | - Shiyu Bai
- Hefei national Research Center for Physical Sciences at the Microscale, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
| | - Qielan Wu
- Hefei national Research Center for Physical Sciences at the Microscale, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
| | - Sanwei Chen
- The First Affiliated Hospital of Anhui Medical University, Hefei, China
| | - Shuhang Li
- Hefei national Research Center for Physical Sciences at the Microscale, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
| | - Di Xie
- Hefei national Research Center for Physical Sciences at the Microscale, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
| | - Rong Lv
- Anhui Blood Center, Heifei, China
| | - Yusheng Chen
- Institute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei, China
| | - Yucai Wang
- Hefei national Research Center for Physical Sciences at the Microscale, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
- Biomedical Sciences and Health Laboratory of Anhui Province, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
| | - Sicheng Fu
- Hefei national Research Center for Physical Sciences at the Microscale, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
| | - Huimin Zhang
- Hefei national Research Center for Physical Sciences at the Microscale, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
| | - Li Bai
- Hefei national Research Center for Physical Sciences at the Microscale, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
- Institute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei, China.
- Biomedical Sciences and Health Laboratory of Anhui Province, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
- National Synchrotron Radiation Laboratory, University of Science and Technology of China, Hefei, China.
| |
Collapse
|
43
|
Zhang H, Okuyama H, Jain A, Jadhav RR, Wu B, Sturmlechner I, Morales J, Ohtsuki S, Weyand CM, Goronzy JJ. PREX1 improves homeostatic proliferation to maintain a naive CD4+ T cell compartment in older age. JCI Insight 2024; 9:e172848. [PMID: 38329813 DOI: 10.1172/jci.insight.172848] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2023] [Accepted: 01/31/2024] [Indexed: 02/10/2024] Open
Abstract
The human adult immune system maintains normal T cell counts and compensates for T cell loss throughout life, mainly through peripheral homeostatic proliferation after the ability of the thymus to generate new T cells has rapidly declined at adolescence. This process is mainly driven by STAT5-activating cytokines, most importantly IL-7, and is very effective in maintaining a large naive CD4+ T cell compartment into older age. Here, we describe that naive CD4+ T cells undergo adaptations to optimize IL-7 responses by upregulating the guanine-nucleotide exchange factor PREX1 in older age. PREX1 promotes nuclear translocation of phosphorylated STAT5, thereby supporting homeostatic proliferation in response to IL-7. Through the same mechanism, increased expression of PREX1 also biases naive cells to differentiate into effector T cells. These findings are consistent with the concept that primarily beneficial adaptations during aging, i.e., improved homeostasis, account for unfavorable functions of the aged immune system, in this case biased differentiation.
Collapse
Affiliation(s)
| | | | | | | | - Bowen Wu
- Department of Medicine, Division of Rheumatology, and
| | | | - Jose Morales
- Department of Medicine, Division of Rheumatology, and
| | - Shozo Ohtsuki
- Department of Medicine, Division of Rheumatology, and
| | - Cornelia M Weyand
- Department of Immunology
- Department of Medicine, Division of Rheumatology, and
| | - Jӧrg J Goronzy
- Department of Immunology
- Department of Medicine, Division of Rheumatology, and
- Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota, USA
| |
Collapse
|
44
|
Zhao H, Liu Y, Zhang X, Liao Y, Zhang H, Han X, Guo L, Fan B, Wang W, Lu C. Identifying novel proteins for suicide attempt by integrating proteomes from brain and blood with genome-wide association data. Neuropsychopharmacology 2024:10.1038/s41386-024-01807-4. [PMID: 38317018 DOI: 10.1038/s41386-024-01807-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/29/2023] [Revised: 12/28/2023] [Accepted: 01/16/2024] [Indexed: 02/07/2024]
Abstract
Genome-wide association studies (GWASs) have identified risk loci for suicide attempt (SA), but deciphering how they confer risk for SA remains largely unknown. This study aims to identify the key proteins and gain insights into SA pathogenesis. We integrated data from the brain proteome (N = 376) and blood proteome (N = 35,559) and combined it with the largest SA GWAS summary statistics to date (N = 518,612). A comprehensive set of methods was employed, including Mendelian randomization (MR), Steiger filtering, Bayesian colocalization, proteome‑wide association studies (PWAS), transcript-levels, cell-type specificity, correlation, and protein-protein interaction (PPI) network analysis. Validation was performed using other protein datasets and the SA dataset from FinnGen study. We identified ten proteins (GLRX5, GMPPB, B3GALTL, FUCA2, TTLL12, ADCK1, MMAA, HIBADH, ACP1, DOC2A) associated with SA in brain proteomics. GLRX5, GMPPB, and FUCA2 showed strong colocalization evidence and were supported by PWAS and transcript-level analysis, and were predominantly expressed in glutamatergic neuronal cells. In blood proteomics, one significant protein (PEAR1) and three near-significant proteins (NDE1, EVA1C, B4GALT2) were identified, but lacked colocalization evidence. Moreover, despite the limited correlation between the same protein in brain and blood, the PPI network analysis provided new insights into the interaction between brain and blood in SA. Furthermore, GLRX5 was associated with the GSTP1, the target of Clozapine. The comprehensive analysis provides strong evidence supporting a causal association between three genetically determined brain proteins (GLRX5, GMPPB, and FUCA2) with SA. These findings offer valuable insights into SA's underlying mechanisms and potential therapeutic approaches.
Collapse
Affiliation(s)
- Hao Zhao
- Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, China
- Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Sun Yat-sen University, Guangzhou, China
| | - Yifeng Liu
- Department of Psychiatry, Shenzhen Nanshan Center for Chronic Disease Control, Shenzhen, China
| | - Xuening Zhang
- Department of Epidemiology and Health Statistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China
| | - Yuhua Liao
- Department of Psychiatry, Shenzhen Nanshan Center for Chronic Disease Control, Shenzhen, China
| | - Huimin Zhang
- Department of Psychiatry, Shenzhen Nanshan Center for Chronic Disease Control, Shenzhen, China
| | - Xue Han
- Department of Psychiatry, Shenzhen Nanshan Center for Chronic Disease Control, Shenzhen, China
| | - Lan Guo
- Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, China
- Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Sun Yat-sen University, Guangzhou, China
| | - Beifang Fan
- Department of Psychiatry, Shenzhen Nanshan Center for Chronic Disease Control, Shenzhen, China.
| | - Wanxin Wang
- Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, China.
- Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Sun Yat-sen University, Guangzhou, China.
| | - Ciyong Lu
- Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, China
- Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Sun Yat-sen University, Guangzhou, China
| |
Collapse
|
45
|
Zhang H, Cong X, Chen C, Liu Z. Sintilimab combined with axitinib in the treatment of advanced chromophobe renal cell carcinoma: a case report. Front Oncol 2024; 14:1325999. [PMID: 38371628 PMCID: PMC10869506 DOI: 10.3389/fonc.2024.1325999] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2023] [Accepted: 01/11/2024] [Indexed: 02/20/2024] Open
Abstract
Chromophobe renal cell carcinoma (ChRCC) is a rare pathological type of renal cell carcinoma (RCC). Related systematic studies involving large numbers of patients are lacking, and more importantly, there is currently no international consensus on post-line treatment guidelines for ChRCC. The rapid development of systemic treatment with molecular targeted therapies and immune checkpoint inhibitors has brought effective approaches for patients with clear cell renal cell carcinoma (ccRCC), while progress in the treatment of ChRCC is still limited. In this case report, the patient was initially diagnosed at the early stage; 4 years post-surgery, she developed lung metastases and the disease progressed once again after being treated with sunitinib monotherapy for 3 years. However, after combining the immunotherapy sintilimab with the targeted therapy axitinib as second-line treatment, imageological examination showed lesions in the lungs that gradually decreased, and the bone metastases remained stable. To date, the patient has been continuously treated for over 2 years and is still undergoing regular treatment and follow-up. This case is the first to report the long-term survival of metastatic disease by using this treatment regimen and to propose a potential therapeutic option for patients with metastatic ChRCC. Since only one case was observed in this report, further study is needed.
Collapse
Affiliation(s)
| | | | | | - Ziling Liu
- Cancer Center, The First Hospital of Jilin University, Changchun, China
| |
Collapse
|
46
|
Hua B, Wu J, Han X, Bian X, Xu Z, Sun C, Wang R, Zhang W, Liang F, Zhang H, Li S, Li Z, Wu S. Auxin homeostasis is maintained by sly-miR167-SlARF8A/B-SlGH3.4 feedback module in the development of locular and placental tissues of tomato fruits. New Phytol 2024; 241:1177-1192. [PMID: 37985404 DOI: 10.1111/nph.19391] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/28/2022] [Accepted: 10/20/2023] [Indexed: 11/22/2023]
Abstract
The locular gel, produced by the placenta, is important for fruit flavor and seed development in tomato. However, the mechanism underlying locule and placenta development is not fully understood yet. Here, we show that two SlARF transcription factors, SlARF8B and SlARF8A (SlARF8A/B), promote the development of locular and placenta tissues. The expression of both SlARF8A and SlARF8B is repressed by sly-microRNA167 (sly-miR167), allowing for the activation of auxin downstream genes. In slarf8a, slarf8b, and slarf8a/b mutants, the auxin (IAA) levels are decreased, whereas the levels of inactive IAA conjugates including IAA-Ala, IAA-Asp, and IAA-Glu are increased. We further find that SlARF8B directly inhibits the expression of SlGH3.4, an acyl acid amino synthetase that conjugates the amino acids to IAA. Disruption of such auxin balance by the increased expression of SlGH3.4 or SlGH3.2 results in defective locular and placental tissues. Taken together, our findings reveal an important regulatory module constituted by sly-miR167-SlARF8A/B-SlGH3.4 during the development of locular and placenta tissues of tomato fruits.
Collapse
Affiliation(s)
- Bing Hua
- College of Horticulture, Haixia Institute of Science and Technology, Fujian Agriculture and Forestry University, Fuzhou, 350002, China
- College of Horticulture and Landscape Architecture, Yangzhou University, Yangzhou, 225009, China
| | - Junqing Wu
- College of Horticulture, Haixia Institute of Science and Technology, Fujian Agriculture and Forestry University, Fuzhou, 350002, China
| | - Xiaoqian Han
- College of Horticulture, Haixia Institute of Science and Technology, Fujian Agriculture and Forestry University, Fuzhou, 350002, China
| | - Xinxin Bian
- College of Horticulture, Haixia Institute of Science and Technology, Fujian Agriculture and Forestry University, Fuzhou, 350002, China
| | - Zhijing Xu
- Key Laboratory of Horticultural Plant Biology, Ministry of Education, Huazhong Agricultural University, Wuhan, 430070, China
| | - Chao Sun
- College of Horticulture, Haixia Institute of Science and Technology, Fujian Agriculture and Forestry University, Fuzhou, 350002, China
| | - Renyin Wang
- College of Horticulture, Haixia Institute of Science and Technology, Fujian Agriculture and Forestry University, Fuzhou, 350002, China
| | - Wenyan Zhang
- College of Horticulture and Landscape Architecture, Yangzhou University, Yangzhou, 225009, China
| | - Fei Liang
- College of Horticulture and Landscape Architecture, Yangzhou University, Yangzhou, 225009, China
| | - Huimin Zhang
- College of Horticulture and Landscape Architecture, Yangzhou University, Yangzhou, 225009, China
| | - Shuang Li
- College of Horticulture, Haixia Institute of Science and Technology, Fujian Agriculture and Forestry University, Fuzhou, 350002, China
| | - Zhengguo Li
- Key Laboratory of Plant Hormones and Development Regulation of Chongqing, School of Life Sciences, Chongqing University, Chongqing, 401331, China
| | - Shuang Wu
- College of Horticulture, Haixia Institute of Science and Technology, Fujian Agriculture and Forestry University, Fuzhou, 350002, China
| |
Collapse
|
47
|
Zhao L, Maimaitiyiming R, Hong J, Wang L, Mu Y, Liu B, Zhang H, Chen K, Aihaiti A. Optimization of tomato ( Solanum lycopersicum L.) juice fermentation process and analysis of its metabolites during fermentation. Front Nutr 2024; 11:1344117. [PMID: 38362104 PMCID: PMC10868405 DOI: 10.3389/fnut.2024.1344117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2023] [Accepted: 01/09/2024] [Indexed: 02/17/2024] Open
Abstract
Tomato (Solanum lycopersicum L.) is a nutritious fruit and vegetable. Fermentation can be used to enhance their nutritional value. In this study, the tomato juice was co-fermented with multistrains, optimized by uniform experimental design and response surface methodology. Superoxide dismutase activity reached 496.67 U/g and lycopene content reached 77.12μg/g when P. pentosaceus (53.79%), L. casei (13.17%), L. plantarum (19.87%), L. fermentum (13.17%). To gain insight into the dynamics of metabolites during the tomato fermentation juice process multivariate statistical analysis was performed using the UHPLC-QE-MS/MS method. The main metabolites are peptides, amino acids carbohydrates, organic acids, and phospholipids. Carbohydrates were fully retained at the end of fermentation.The content of galactitol increased from the initial 5.389 to 6.607 while the content of cytarabine decreased by 29% and uridine by 44%. Meanwhile, phospholipids (PS, PE, PC, PG, PI) were all retained by more than 70%. Terpenoids (16-deacetylgairin, (+)-Royleanone, artemisinin) were increased to varying degrees, which gives them good nutritional value and biological activity. Organic acids (malic and citric) were reduced and lactic acid content was increased, changing its original flavor and making it more palatable to the general population. The research results have demonstrated the benefits of lactic acid bacteria fermentation on tomato juice, providing a theoretical basis and reference for the fermentation metabolism process of tomato juice.
Collapse
Affiliation(s)
- Lei Zhao
- School of Life Science and Technology, Xinjiang University, Urumqi, China
| | | | - Jingyang Hong
- School of Life Science and Technology, Xinjiang University, Urumqi, China
| | - Liang Wang
- School of Life Science and Technology, Xinjiang University, Urumqi, China
| | - Ying Mu
- School of Life Science and Technology, Xinjiang University, Urumqi, China
| | - Bingze Liu
- School of Life Science and Technology, Xinjiang University, Urumqi, China
| | - Huimin Zhang
- School of Life Science and Technology, Xinjiang University, Urumqi, China
| | - Keping Chen
- Xinjiang Huize Food Limited Liability Company, Urumqi, China
| | | |
Collapse
|
48
|
Lv S, Fu X, Yue Z, Zhang H, Zhou G, Liu H, Zhang F. Photodynamic therapy and CO 2 fractional laser combination therapy for verruca vulgaris caused by Koebner phenomenon - Two case reports. Photodiagnosis Photodyn Ther 2024; 45:103946. [PMID: 38145774 DOI: 10.1016/j.pdpdt.2023.103946] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2023] [Revised: 12/05/2023] [Accepted: 12/19/2023] [Indexed: 12/27/2023]
Abstract
Verruca vulgaris, caused by the human papillomavirus (HPV), can profoundly impact an individual's quality of life and necessitate therapeutic intervention. The challenges associated with treating verruca vulgaris are particularly noteworthy when they manifest as the Koebner phenomenon (KP). In this report, we present two cases of verruca vulgaris that developed KP following cryotherapy. Some studies have suggested that pretreatment with laser therapy enhances the efficacy of Photodynamic Therapy (PDT). Given the inefficacy of cryotherapy and the emergence of KP in our patients, we opted for a treatment approach that combined PDT with CO2 fractional laser (CO2FL), resulting in complete resolution without any notable adverse effects or recurrence during the follow-up period. Our cases underscore the importance of considering KP when verruca vulgaris exhibit enlargement and proliferation post-cryotherapy. Furthermore, this combined treatment modality demonstrates its effectiveness and safety. Additionally, our experience highlights the need for a large-scale study to determine the optimal photosensitizer concentration for the treatment of thick, enlarged verruca vulgaris.
Collapse
Affiliation(s)
- Shuang Lv
- Hospital for Skin Diseases, Shandong First Medical University, Jingshi Lu, 27397, Jinan, Shandong Province, China.
| | - Xi'an Fu
- Hospital for Skin Diseases, Shandong First Medical University, Jingshi Lu, 27397, Jinan, Shandong Province, China; Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences; Jingshi Lu, 27397, Jinan, Shandong Province, China.
| | - Zhenhua Yue
- Hospital for Skin Diseases, Shandong First Medical University, Jingshi Lu, 27397, Jinan, Shandong Province, China; Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences; Jingshi Lu, 27397, Jinan, Shandong Province, China.
| | - Huimin Zhang
- Hospital for Skin Diseases, Shandong First Medical University, Jingshi Lu, 27397, Jinan, Shandong Province, China; Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences; Jingshi Lu, 27397, Jinan, Shandong Province, China.
| | - Guizhi Zhou
- Hospital for Skin Diseases, Shandong First Medical University, Jingshi Lu, 27397, Jinan, Shandong Province, China; Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences; Jingshi Lu, 27397, Jinan, Shandong Province, China.
| | - Hong Liu
- Hospital for Skin Diseases, Shandong First Medical University, Jingshi Lu, 27397, Jinan, Shandong Province, China; Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences; Jingshi Lu, 27397, Jinan, Shandong Province, China.
| | - Furen Zhang
- Hospital for Skin Diseases, Shandong First Medical University, Jingshi Lu, 27397, Jinan, Shandong Province, China; Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences; Jingshi Lu, 27397, Jinan, Shandong Province, China.
| |
Collapse
|
49
|
Zhou T, Xie W, Zhang H, Fan Y. Simple Conditional Spatial Query Mask Deformable Detection Transformer: A Detection Approach for Multi-Style Strokes of Chinese Characters. Sensors (Basel) 2024; 24:931. [PMID: 38339648 PMCID: PMC10857204 DOI: 10.3390/s24030931] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/15/2023] [Revised: 01/20/2024] [Accepted: 01/25/2024] [Indexed: 02/12/2024]
Abstract
In the Chinese character writing task performed by robotic arms, the stroke category and position information should be extracted through object detection. Detection algorithms based on predefined anchor frames have difficulty resolving the differences among the many different styles of Chinese character strokes. Deformable detection transformer (deformable DETR) algorithms without predefined anchor frames result in some invalid sampling points with no contribution to the feature update of the current reference point due to the random sampling of sampling points in the deformable attention module. These processes cause a reduction in the speed of the vector learning stroke features in the detection head. In view of this problem, a new detection method for multi-style strokes of Chinese characters, called the simple conditional spatial query mask deformable DETR (SCSQ-MDD), is proposed in this paper. Firstly, a mask prediction layer is jointly determined using the shallow feature map of the Chinese character image and the query vector of the transformer encoder, which is used to filter the points with actual contributions and resample the points without contributions to address the randomness of the correlation calculation among the reference points. Secondly, by separating the content query and spatial query of the transformer decoder, the dependence of the prediction task on the content embedding is relaxed. Finally, the detection model without predefined anchor frames based on the SCSQ-MDD is constructed. Experiments are conducted using a multi-style Chinese character stroke dataset to evaluate the performance of the SCSQ-MDD. The mean average precision (mAP) value is improved by 3.8% and the mean average recall (mAR) value is improved by 1.1% compared with the deformable DETR in the testing stage, illustrating the effectiveness of the proposed method.
Collapse
Affiliation(s)
- Tian Zhou
- Guangxi Key Laboratory of Image and Graphic Intelligent Processing, Guilin University of Electronic Technology, Guilin 541004, China;
- School of Computer Science and Information Security, Guilin University of Electronic Technology, Guilin 541004, China
| | - Wu Xie
- Guangxi Key Laboratory of Image and Graphic Intelligent Processing, Guilin University of Electronic Technology, Guilin 541004, China;
- School of Computer Science and Information Security, Guilin University of Electronic Technology, Guilin 541004, China
| | - Huimin Zhang
- Key Laboratory of Education Blockchain and Intelligent Technology, Ministry of Education, Guangxi Normal University, Guilin 541004, China
- Guangxi Key Lab of Multi-Source Information Mining and Security, Guangxi Normal University, Guilin 541004, China
| | - Yong Fan
- School of Mechanical and Electrical Engineering, Guilin University of Electronic Technology, Guilin 541004, China;
| |
Collapse
|
50
|
Zhang H, Zhang N, Liu Z, Jiang K, Zhou X. Additional kinetic energy harvesting with extra electrodes by single electrode droplet-based electricity generator (SE-DEG). Heliyon 2024; 10:e24765. [PMID: 38304830 PMCID: PMC10831788 DOI: 10.1016/j.heliyon.2024.e24765] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2023] [Revised: 12/28/2023] [Accepted: 01/14/2024] [Indexed: 02/03/2024] Open
Abstract
The utilization of water energy through the Single Electrode Droplet-Based Electricity Generator (SE-DEG) represents a universal and high-efficiency method for water energy harvesting. Previous research has extensively elucidated the working principle of SE-DEG based on bulk effect. However, scant attention has been paid to the investigation of the electrical characteristics surrounding the SE-DEG. Remarkably, the electrical characteristics around the SE-DEG can be exploited to generate electricity and harvest corresponding energy. Here we evaluate the electrical characteristics around the SE-DEG by arranging extra electrodes. An interesting phenomenon is found that, on the premise of no contact between extra electrodes and the droplet, there is opposite electricity output from extra electrodes synchronously when the droplet contacts on the PTFE film and SE-DEG electrode and outputs the electricity. This phenomenon is comprehensively explained and verified from working mechanism, the impacts of different arrangements and the array design of extra electrodes. Significantly, utilizing the electrical characteristics could harvest additional kinetic energy with extra electrodes in SE-DEG. This investigation is expected to provide new insights into the future harnessing of water kinetic energy within the SE-DEG framework.
Collapse
Affiliation(s)
- Huimin Zhang
- School of Integrated Circuits, East China Normal University, Shanghai, 200241, China
| | - Nan Zhang
- School of Integrated Circuits, East China Normal University, Shanghai, 200241, China
| | - Zhourui Liu
- School of Integrated Circuits, East China Normal University, Shanghai, 200241, China
| | - Ke Jiang
- School of Integrated Circuits, Tsinghua University, Beijing, 100084, China
| | - Xiaofeng Zhou
- School of Integrated Circuits, East China Normal University, Shanghai, 200241, China
| |
Collapse
|